Farfour E, Vasse M, Vallée A. Mollicutes-related infections in thoracic surgery including lung and heart transplantation: A systematic review J Heart Lung Transplant . 2024 Jan

Atsou S, Schellenberg C, Lagrange J, Lacolley P, Lenting PJ, Denis CV, Christophe OD, Regnault V. Thrombin generation on vascular cells in the presence of factor VIII and/or emicizumab. J Thromb Haemost. 2023 Sep 29

Bareille M, Lecompte T, Mullier F, Roullet S. Are Viscoelastometric Assays of Old Generation Ready for Disposal? Comment on Volod et al. Viscoelastic Hemostatic Assays: A Primer on Legacy and New Generation Devices. J Clin Med. 2023 Jan 6;12(2):477.

Bentounes NK, Lasne D, Habay C, Bally C, Frenzel L, Harroche A, Borgel D, Auditeau C. The effects of time and temperature on the in vitro stability of emicizumab in blood samples: Implications for laboratory and clinical practices Haemophilia . 2023 Dec 25

Bou-Jaoudeh M, Mimoun A, Delignat S, Peyron I, Capdevila L, Daventure V, Deligne C, Dimitrov JD, Christophe OD, Denis CV, Lenting PJ, Proulle V, Lacroix-Desmazes S. Imlifidase, a new option to optimize the management of patients with hemophilia A on emicizumab. J Thromb Haemost . 2023 Oct;21

Boussard C, Delage L, Gajardo T, Kauskot A, Batignes M, Goudin N, Stolzenberg MC, Brunaud C, Panikulam P, Riller Q, Moya-Nilges M, Solarz J, Reperant C, Durel B, Bordet JC, Pellé O, Lebreton C, Magerus-Chatinet A, Pirabakaran V, Vargas P, Dupichaud S, Jeanpierre M, Vinit A, Zarhrate M, Masson C, Aladjidi N, Arkwright PD, Bader-Meunier B, Baron Joly S, Benadiba J, Bernard E, Berrebi D, Bodemer C, Castelle M, Charbit-Henrion F, Chbihi M, Debray A, Drabent P, Fraitag S, Hié M, Landman-Parker J, Lhermitte L, Moshous D, Rohrlich P, Ruemmele FM, Welfringer-Morin A, Tusseau M, Belot A, Cerf-Bensussan N, Roelens M, Picard C, Neven B, Fischer A, Callebaut I, Ménager MM, Sepulveda FE, Adam F, Rieux-Laucat F.  DOCK11 deficiency in patients with X-linked actinopathy and autoimmunity. Blood . 2023 Mar 23;blood.2022018486.

Cardot-Martin E, Colombier MA, Limousin L, Farfour E, Lesprit P, Vasse M. Reply to comments on « Impact of EUCAST rapid Antimicrobial Susceptibility testing (RAST) on management of Gram-negative bloodstream infection ». Infect Dis Now. 2023 Feb 2;53(2):104667.

Chauvin C, Levillayer L, Roumier M, Nielly H, Roth C, Karnam A, Bonam SR, Bourgarit A, Dubost C, Bousquet A, Le Burel S, Mestiri R, Sene D, Galland J, Vasse M, Groh M, Le Marchand M, Vassord-Dang C, Gautier JF, Pham-Thi N, Verny C, Pitard B, Planchais C, Mouquet H, Paul R, Simon-Loriere E, Bayry J, Gilardin L, Sakuntabhai A. Tocilizumab-treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants. iScience. 2023 Mar 17;26(3):106124.

Chenesseau J, Fourdrain A, Pastene B, Charvet A, Rivory A, Baumstarck K, Bouabdallah I, Trousse D, Boulate D, Brioude G, Gust L, Vasse M, Braggio C, Mora P, Labarriere A, Zieleskiewicz L, Leone M, Thomas PA, D’Journo XB. Effectiveness of Surgeon-Performed Paravertebral Block Analgesia for Minimally Invasive Thoracic Surgery: A Randomized Clinical Trial JAMA Surg . 2023 Dec 1

de Fréminville A, Saad M, Sage E, Pricopi C, Fischler M, Trillat B, Salze B, Pascreau T, Vasse M, Vallée A, Guen ML, Fessler J. Relationship Between Preoperative Inflammation Ratios Derived From Preoperative Blood Cell Count and Postoperative Pulmonary Complications in Patients Undergoing Lobectomy: A Single-Center Observational Study. J Cardiothorac Vasc Anesth . 2023 Nov 4:

Dubar V, Pascreau T, Dupont A, Dubucquoi S, Dautigny AL, Ghozlan B, Zuber B, Mellot F, Vasse M, Susen S, Poissy J, Gaudet A. Development of a Decision Support Tool for Anticoagulation in Critically Ill Patients Admitted for SARS-CoV-2 Infection: The CALT Protocol. Biomedicines . 2023 May 23;11(6):1504.

Farfour E, Clichet V, Péan de Ponfilly G, Carbonnelle E, Vasse M.  Impact of COVID-19 pandemic on blood culture practices and bacteremia epidemiology. Diagn Microbiol Infect Dis. 2023 Jun 8;107(1):116002

Farfour E, d’Epenoux LR, Muggeo A, Alauzet C, Crémet L, Moussalih S, Roux A, de Verdière SC, Bosphore A, Corvec S, Guillard T, Vasse M. In vitro susceptibility of nonfermenting Gram-negative rods to meropenem-vaborbactam and delafloxacin. Future Microbiol . 2023 Feb 1. doi: 10.2217/fmb-2021-0278.

Farfour E, Le Brun C, Degand N, Riverain E, Dinh A, Timores T, Mamona C, Vallée A, Vasse M. Impact of revised breakpoints on the categorization of susceptibility of Enterobacterales to temocillin JAC Antimicrob Resist . 2023 Nov 1

Farfour É, Rouabah L, Bargain P, Lecuru M, Picard C, Tcherakian C, Maneglier B, Juillet SM, Vasse M. Trend in respiratory viruses’ activity in the COVID-19 area Ann Biol Clin (Paris) . 2023 Oct 20

Farfour E, Roux A, Sage E, Revillet H, Vasse M, Vallée A.  Rarely Encountered Gram-Negative Rods and Lung Transplant Recipients: A Narrative Review. Microorganisms . 2023 May 31;11(6):1468

Farfour E, Zrounba M, Roux A, Revillet H, Vallée A, Vasse M.  Inquilinus limosus Bacteremia in Lung Transplant Recipient after SARS-CoV-2 Infection. Emerg Infect Dis. 2023 Mar;29(3):642-644

Feng M, Hechler B, Adam F, Gachet C, Eckly A, Kauskot A, Denis CV, Bryckaert M, Bobe R, Rosa JP. ADP receptor P2Y12 is the capstone of the cross-talk between Ca²⁺ mobilization pathways dependent on Ca²⁺ ATPases sarcoplasmic/endoplasmic reticulum type 3 and type 2b in platelets. Res Pract Thromb Haemost . 2022 Nov 29;7(1):100004

Gaborit B, Vanhove B, Lacombe K, Guimard T, Hocqueloux L, Perrier L, Dubee V, Ferre V, Bressollette C, Josien R, Thuaut AL, Vibet MA, Jobert A, Dailly E, Ader F, Brouard S, Duvaux O, Raffi F; POLYCOR study group. Effect of Swine Glyco-humanized Polyclonal Neutralizing Antibody on Survival and Respiratory Failure in Patients Hospitalized With Severe COVID-19: A Randomized, Placebo-Controlled Trial Open Forum Infect Dis . 2023 Oct 20

Gay J, Le Beller C, Asgari R, Chocron R, Bajolle F, Auger L, Mimoun A, Borgel D, Lillo-Le-Louet A, Lasne D. Heparin-induced thrombocytopenia in newborns: experience at a pediatric hospital and a literature review Res Pract Thromb Haemost . 2023 Sep 29

Gravrand V, Mellot F, Ackermann F, Ballester MC, Zuber B, Kirk JT, Navalkar K, Yager TD, Petit F, Pascreau T, Farfour E, Vasse M. Stratification of COVID-19 Severity Using SeptiCyte RAPID, a Novel Host Immune Response Test. Viruses. 2023 Feb 2;15(2):419

Guillet B, Hassoun A, Wibaut B, Harroche A, Biron-Andréani C, Repesse Y, d’Oiron R, Tardy B, Pan Petesch B, Chamouni P, Gay V, Fouassier M, Pouplard C, Martin C, Catovic H, Delavenne X. A French Real-World Evidence Study Evaluating the Efficacy, Safety, and Pharmacokinetic Parameters of rVIII-SingleChain in Patients with Hemophilia A Receiving Prophylaxis. Thromb Haemost . 2023 May;123(5):490-500

Habay C, Auditeau C, Blandinières A, Bentounes NK, Lavenu-Bombled C, Harroche A, Bally C, Frenzel L, Borgel D, Lasne D. Interferences by factor VIII and lupus anticoagulant in the modified one-stage assay for emicizumab Haemophilia . 2023 Nov;29

Hermans C, Astermark J, Carvalho M, Dolan G, d’Oiron R, Fontana P, Holme PA, Kenet G, Klamroth R, Mancuso ME, Marquardt N, Nunez R, Katsarou O, Pabinger-Fasching I, Quintavalle G, Rodgers R, van der Valk P, Windyga J, Jimenez Yuste V, Preložnik Zupan I. Prevalence of COVID-19 related hospitalizations and mortality in adults aged ≥40 years with haemophilia: A survey from Europe. Haemophilia . 2023 Feb 18. doi: 10.1111/hae.14761.

Kauskot A, Mallebranche C, Bruneel A, Fenaille F, Solarz J, Viellard T, Feng M, Repérant C, Bordet JC, Cholet S, Denis CV, McCluskey G, Latour S, Martin E, Pellier I, Lasne D, Borgel D, Kracker S, Ziegler A, Tuffigo M, Fournier B, Miot C, Adam F.  MAGT1 deficiency in XMEN disease is associated with severe platelet dysfunction and impaired platelet glycoprotein N-glycosylation. J Thromb Haemost . 2023 May 18

Kizlik-Masson C, Peyron I, Gangnard S, Le Goff G, Lenoir SM, Damodaran S, Clavel M, Roullet S, Regnault V, Rauch A, Vincent F, Jeanpierre E, Dupont A, Ternisien C, Donnet T, Christophe OD, van Belle E, Denis CV, Casari C, Susen S, Lenting PJ. A nanobody against the von Willebrand factor A3-domain detects ADAMTS13-induced proteolysis in congenital & acquired VWD. Blood. 2023 Mar 23;141(12):1457-1468

Lenting PJ, Texier A, Casari C. von Willebrand factor: from figurant to main character in the scene of inflammation. J Thromb Haemost . 2023 Apr;21(4):710-713.

Lewis CS, Bari K, Xie C, Sherman KE, Vasse M, Van Dreden P, Bogdanov VY. Potential utility of a multi-component coagulation factor panel to calculate MELD scores and assess the risk of portal vein thrombosis in chronic liver disease. BMC Gastroenterol. 2023 Mar 9;23(1):65

Martin EC, Limousin L, Renaux C, Catherinot E, Vasse M. Evaluation of the mycobacteria MBT kit for identification of nontuberculous mycobacteria by MALDI-TOF Biotyper (Bruker) Diagn Microbiol Infect Dis . 2023 Nov

Mimoun A, Bou-Jaoudeh M, Delignat S, Daventure V, Reyes Ruiz A, Lecerf M, Azam A, Noe R, Peyron I, Christophe OD, Lenting PJ, Proulle V, McIntosh J, Nathwani AC, Dimitrov JD, Denis CV, Lacroix-Desmazes S. Transplacental delivery of therapeutic proteins by engineered immunoglobulin G: a step toward perinatal replacement therapy. J Thromb Haemost. 2023 Sep

Négrier C, Mahlangu J, Lehle M, Chowdary P, Catalani O, Bernardi RJ, Jiménez-Yuste V, Beckermann BM, Schmitt C, Ventriglia G, Windyga J, d’Oiron R, Moorehead P, Koparkar S, Teodoro V, Shapiro AD, Oldenburg J, Hermans C. Emicizumab in people with moderate or mild haemophilia A (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study. Lancet Haematol . 2023 Mar;10(3):e168-e177.

Pascreau T, Auditeau C, Borgel D. Hemostatic defects in congenital disorders of glycosylation Res Pract Thromb Haemost . 2023 Mar 30

Pascreau T, Gougeon M, Fessler J, Zia Chahabi S, Le Guen M, Vasse M. Interest in the new thromboelastometry device, Clot Pro®, for predicting thrombocytopenia and hypofibrinogenemia during lung transplantation. Thromb Res . 2023 Nov 28

Pascreau T, Zia-Chahabi S, Vasse M. Letter to the editor regarding « Protein Z and Protein Z-dependent protease inhibitor in patients with acute ischemic stroke: A prospective mechanistic study ». J Stroke Cerebrovasc Dis . 2023 Nov 10

Rauch A, Dupont A, Rosa M, Desvages M, Le Tanno C, Abdoul J, Didelot M, Ung A, Ruez R, Jeanpierre E, Daniel M, Corseaux D, Spillemaeker H, Labreuche J, Pradines B, Rousse N, Lenting PJ, Moussa MD, Vincentelli A, Bordet JC, Staels B, Vincent F, Denis CV, Van Belle E, Casari C, Susen S. Shear Forces Induced Platelet Clearance Is a New Mechanism of Thrombocytopenia. Circ Res. 2023 Oct 27

Rossi E, Pericacho M, Kauskot A, Gamella-Pozuelo L, Reboul E, Leuci A, Egido-Turrion C, El Hamaoui D, Marchelli A, Fernández FJ, Margaill I, Vega MC, Gaussem P, Pasquali S, Smadja DM, Bachelot-Loza C, Bernabeu C.  Soluble endoglin reduces thrombus formation and platelet aggregation via interaction with αIIbβ3 integrin. J Thromb Haemost . 2023 Mar 28

Roullet S, Luc N, Rayes J, Solarz J, Disharoon D, Ditto AJ, Gahagan E, Pawlowski C, Sefiane T, Adam F, Casari C, Christophe OD, Bruckman MA, Lenting PJ, Sen Gupta A, Denis CV. Efficacy of platelet-inspired hemostatic nanoparticles on bleeding in Von Willebrand disease murine models. Blood. 2023 Mar 17:blood.2022018956.

Schellenberg C, Lagrange J, Ahmed MU, Arnone D, Campoli P, Louis H, Touly N, Caron B, Plénat F, Perrin J, Lenting PJ, Regnault V, Lacolley P, Denis CV, Peyrin-Biroulet L. The role of platelets and von Willebrand factor in the procoagulant phenotype of inflammatory bowel disease. J Crohns Colitis . 2023 Nov 27

Sefiane T, Maynadié H, Ettingshausen CE, Muczynski V, Heiligenstein X, Dumont J, Christophe OD, Denis CV, Casari C, Lenting PJ. Differences in venous clot structures between hemophilic mice treated with emicizumab versus factor VIII or factor VIIIFc. Haematologica . 2023 Dec 7.

Texier A, Lenting PJ, Denis CV, Roullet S, Christophe OD. Angiopoietin-2 binds to multiple interactive sites within von Willebrand factor. Res Pract Thromb Haemost . 2023 Sep 19

Vasse M, Sukhachev D, Ballester MC, Delcominette F, Mellot F, Habarou F, Védrenne A, Jolly E, Sukhacheva E, Farfour E, Pascreau T. Prognostic value of cellular population data in patients with COVID-19. Inform Med Unlocked. 2023;38:101207

Wicker C, Roux CJ, Goujon L, de Feraudy Y, Hully M, Brassier A, Bérat CM, Chemaly N, Wiedemann A, Damaj L, Abi-Warde MT, Dobbelaere D, Roubertie A, Cano A, Arion A, Kaminska A, Da Costa S, Bruneel A, Vuillaumier-Barrot S, Boddaert N, Pascreau T, Borgel D, Kossorotoff M, Harroche A, de Lonlay P. Association between acute complications in PMM2-CDG patients and haemostasis anomalies: Data from a multicentric study and suggestions for acute management  Mol Genet Metab . 2023 No

Young G, Lenting PJ, Croteau SE, Nolan B, Srivastava A. Antithrombin lowering in hemophilia: a closer look at fitusiran. Res Pract Thromb Haemost . 2023 May 16

Adam F, Kauskot A , Lamrani L, Solarz J, Soukaseum C, Repérant C, Denis CV, Raslova H, Rosa JP, Bryckaert M.  A gain-of-function filamin A mutation in mouse platelets induces thrombus instability. J Thromb Haemost. 2022 Aug 25.

Astermark J, Ay C, Carvalho M, D’Oiron R, Moerloose P, Dolan G, Fontana P, Hermans C, Holme PA, Katsarou O, Kenet G, Klamroth R, Mancuso ME, Marquardt N, Núñez R, Pabinger I, Tait R, Valk PV. New Inhibitors in the Ageing Population: A Retrospective, Observational, Cohort Study of New Inhibitors in Older People with Hemophilia. Thromb Haemost. 2022 Jun;122(6):905-912.

Bianchini EP. Antithrombin deficiciency: no sugar, no diagnosis. Blood. 2022, 140, 83-85.

Bianchini E, Auditeau C, Borgel D. How can the design of therapeutic SERPINs be improved? J Thromb Haemost. 2022 May;20(5):1037-1039.

Bianchini EP, Razanakolona M, Boisrame-Helms J, Zouiti F, Couteau-Chardon A, Marin-Esteban V, de Chaisemartin L, De Carvalho A, Bironien R, Chollet-Martin S, Denis C, Diehl JL, Vasse M, Meziani F, Borgel D. The proteolytic inactivation of protein Z-dependent protease inhibitor by neutrophil elastase might promote the procoagulant activity of NETs. Thromb Haemost. 2022 Apr;122(4):506-516.

Boittin FX, Beddek K, Thery H, Pateux J, Cosler G, Riccobono D, Drouet M, Bobe R. The immunosuppressant drug Cyclosporin A aggravates irradiation effects in endothelial cells. Biochem Biophys Res Commun. 2022 Apr 30;602:127-134.

Capdevila L, Frère C, Desvages M, Harroche A, Bally C, Abbes A, d’Oiron R, Frenzel L,Borgel D, Lasne D. Emicizumab does not interfere with the activated clotting time. Haemophilia. 2022 Mar;28(2):362-366.

Carbonnel M, Daclin C, Tarantino N, Groiseau O, Morin V, Rousseau A, Vasse M, Hertig A, Kennel T, Ayoubi JM, Vieillard V. Plasticity of natural killer cells in pregnant patients infected with SARS-CoV-2 and their neonates during childbirth. Front Immunol. 2022 Jul 15;13:893450.

Carbonnel M, Daclin C, Tourne M, Roux E, Le-Marchand M, Racowsky C, Kennel T, Farfour E, Vasse M, Ayoubi JM. Impact of COVID-19 on Subclinical Placental Thrombosis and Maternal Thrombotic Factors. J Clin Med. 2022 Jul 14;11(14):4067.

Cardot Martin E, Dolidon S, Lesprit P, Vasse M, Pereyre S. A strain uncoloured by Gram staining in a pleural fluid. Clin Microbiol Infect. 2022 Jul;28(7):973-974.

Cardot Martin E, Colombier MA, Limousin L, Daude O, Izarn O, Cahen P, Farfour E, Lesprit P, Vasse M. Impact of EUCAST rapid antimicrobial susceptibility testing (RAST) on management of Gram-negative bloodstream infection. Infect Dis Now. 2022, 52, 421-425.

Caroff J, Aubert L, Lavenu-Bombled C, Figueiredo S, Habchi K, Cortese J, Eugene F, Ognard J, Tahon F, Forestier G, Ifergan H, Zhu F, Hak JF, Reyre A, Laubacher M, Traore A, Desilles JP, Derraz I, Moreno R, Bintner M, Charbonnier G, Le Bras A, Veunac L, Gariel F, Redjem H, Sedat J, Tessier G, Dumas V, Gauberti M, Chivot C, Consoli A, Bricout N, Tuilier T, Guedon A, Pop R, Thouant P, Bellanger G, Zannoni R, Soize S, Richter JS, Heck O, Mihalea C, Burel J, Girot JB, Shotar E, Gazzola S, Boulouis G, Kerleroux B; JENI Research Collaboration. Antithrombotic therapies for neurointerventional surgery: a 2021 French comprehensive national survey. J Neurointerv Surg. 2022 Mar 28:neurintsurg-2021-018601.

Casari C, Favier R, Legendre P, Kauskot A, Adam F, Picard V, Lenting PT, Denis CV, Proulle V. A thrombopoietin receptor agonist to rescue an unusual platelet transfusion-induced reaction in a p.V1316M-associated von Willebrand disease type 2B patient. Ther Adv Hematol. 2022 Feb 16;13:20406207221076812. 

Coppée R, Chenane HR, Bridier-Nahmias A, Tcherakian C, Catherinot E, Collin G, Lebourgeois S, Visseaux B, Descamps D, Vasse M, Farfour E. Temporal dynamics of RSV shedding and genetic diversity in adults during the COVID-19 pandemic in a French hospital, early 2021. Virus Res. 2022 Sep 29;323:198950.

de Maat S, Clark C, Barendrecht AD, Smits S, van Kleef ND, El Otmani H, Waning M, van Moorsel MVA, Szardenings M, Delaroque N, Vercruysse K, Urbanus RT, Sebastian S, Lenting PJ, Hagemeyer CE, Renné T, Vanhoorelbeke K, Tersteeg C, Maas C. Microlyse; a thrombolytic agent that targets VWF for clearance of microvascular thrombosis. Blood. 2022 Jan 27;139(4):597-607.

D’Oiron R: [Young girls and women with congenital bleeding disorders – The challenges of early diagnosis]. Rev Med Suisse. 2022 Dec 7;18(807):2319-2322.

Denis CV, Lenting PJ. How to keep the FVIII/VWF complex in the circulation. Haematologica. 2022 Sep 1;107(9):2011-2013.

Denis CV, Lenting PJ, Wahl D. TaSER: Combining forces to stop the clot. J Thromb Haemost. 2022, 20, 293-295.

Denis CV, Roullet S, Perrin J. Von Willebrand factor and cancer: Another piece of the puzzle. J Thromb Haemost. 2022 Jul 29.

Desilles JP, Solo Nomenjanahary M, Consoli A, Ollivier V, Faille D, Bourrienne MC, Hamdani M, Dupont S, Di Meglio L, Escalard S, Maier B, Blanc R, Piotin M, Lapergue B, Ajzenberg N, Vasse M, Mazighi M, Ho-Tin-Noé B; compoCLOT study group. Impact of COVID-19 on thrombus composition and response to thrombolysis: Insights from a monocentric cohort population of COVID-19 patients with acute ischemic stroke. J Thromb Haemost. 2022 Apr;20(4):919-928.

Dubois MD, Peyron I, Pierre-Louis ON, Pierre-Louis S, Rabout J, Boisseau P, de Jong A, Susen S, Goudemand J, Neviere R, Fuseau P, Christophe OD, Lenting PJ, Denis CV, Casari C. Identification of von Willebrand factor D4 domain mutations in patients of Afro-Caribbean descent: In vitro characterization. Res Pract Thromb Haemost. 2022 Jun 15;6(4):e12737.

Farfour E, Dortet L, Guillard T, Chatelain N, Poisson A, Mizrahi A, Fournier D, Bonnin RA, Degand N, Morand P, Janvier F, Fihman V, Corvec S, Broutin L, Le Brun C, Yin N, Héry-Arnaud G, Grillon A, Bille E, Jean-Pierre H, Amara M, Jaureguy F, Isnard C, Cattoir V, Diedrich T, Flevin E, Merens A, Jacquier H, Vasse M, On Behalf Of The Gmc Study Group. Antimicrobial Resistance in Enterobacterales Recovered from Urinary Tract Infections in France. Pathogens. 2022 Mar 15;11(3):356.

Farfour E, Lebourgeois S, Chenane HR, Charpentier C, Pascreau T, Jolly E, Descamps D, Vasse M, Visseaux B. SARS-CoV-2 viability and viral RNA persistence on microbiological agar plates. J Hosp Infect. 2022 Dec 6:S0195-6701(22)00368-1.

Farfour E, Le Brun C, Mizrahi A, Bargain P, Durieux MF, Boquel F, Corvec S, Jeddi F, Muggeo A, Huguenin A, Barraud O, Amara M, Fihman V, Bailly E, Botterel F, Guillard T, Vasse M; GMC study group. Contribution of the anaerobic blood culture vial for the recovery of Candida glabrata: A retrospective multicentric study. Med Mycol. 2022 Apr 29;60(4):myac021.

Farfour E, Pascreau T, Zia-Chahabi S, Jolly É, Ferrière P, Mazaux L, Vasse M. Comparison of two SARS-CoV-2 RT-PCR assays and implication of the instrument software on cycle threshold (Ct) value. Ann Biol Clin (Paris). 2022 Nov 1;80(6):537-540. 

Farfour E, Yung T, Baudoin R, Vasse M. Evaluation of Four Fully Integrated Molecular Assays for the Detection of Respiratory Viruses during the Co-Circulation of SARS-CoV-2, Influenza and RSV.  J Clin Med. 2022 Jul 6;11(14):3942.

Fessler J, Vallée A, Guirimand A, Sage E, Glorion M, Roux A, Brugière O, Parquin F, Zuber B, Cerf C, Vasse M, Pascreau T, Fischler M, Ichai C, Guen ML. Blood Lactate During Double-Lung Transplantation: A Predictor of Grade-3 Primary Graft Dysfunction. J Cardiothorac Vasc Anesth. 2022 Mar;36(3):794-804.

Fiore M, Sentilhes L, d’Oiron R. How I manage pregnancy in women with Glanzmann thrombasthenia. Blood. 2022 Apr 28;139(17):2632-2641

Hart DP, Matino D, Astermark J, Dolan G, d’Oiron R, Hermans C, Jiménez-Yuste V, Linares A, Matsushita T, McRae S, Ozelo MC, Platton S, Stafford D, Sidonio RF Jr, Tiede A. International consensus recommendations on the management of people with haemophilia B. Ther Adv Hematol. 2022 Apr 2;13:20406207221085202.

Huck V, Chen P-C, Xu E-R, Tischer A, Klemm U, Aponte-Santamaria C, mess C, Obser T, Kutzki F, König G, Denis CV, Gräter F, Wilmanns M, Auton M, Schneider SW, Schneppenheim R, Henning J, Brehm M. Gain-of-function variant p.Pro2555Arg of von Willebrand factor increases aggregate size through altering stem dynamics. Thromb Haemost. 2022 Feb;122(2):226-239.

Hukkinen M, Wong M, Demir Z, Salem RH, Debray D, Renolleau S, Sissaoui S, Lacaille F, Girard M, Oualha M, Querciagrossa S, Fabre M, Lozach C, Clement R, Lasne D, Borgel D, Capito C, Chardot C. Antithrombin supplementation for prevention of vascular thrombosis after pediatric liver transplantation. J Pediatr Surg. 2022 Jul 2:S0022-3468(22)00397-9. 

Lagrange J, Worou ME, Michel JB, Raoul A, Didelot M, Muczynski V, Legendre P, Plénat F, Gauchotte G, Lourenco-Rodrigues MD, Christophe OD, Lenting PJ, Lacolley P, Denis CV, Regnault V. The VWF/LRP4/αVβ3-axis represents a novel pathway regulating proliferation of human vascular smooth muscle cells. Cardiovasc Res. 2022 Jan 29;118(2):622-637. doi: 10.1093/cvr/cvab042.

Lamrani L, Adam F, Soukaseum C, Denis CV, Raslova H, Rosa JP, Bryckaert M. New insights into regulation of αIIbβ3 integrin signaling by filamin A. Res Pract Thromb Haemost. 2022 Mar 16;6(2):e12672.

Lee RH, Ghalloussi D, Harousseau GL, Kenny JP, Kramer PA, Proamer F, Nieswandt B, Flick MJ, Gachet C, Casari C, Eckly A, Bergmeier W. Rasa3 deficiency minimally affects thrombopoiesis but promotes severe thrombocytopenia due to integrin-dependent platelet clearance. JCI Insight. 2022 Apr 22;7(8):e155676.

Lenting PJ, Kizlik-Manson C, Casari C. Towards novel treatment options in von Willebrand disease. Haemophilia. 2022 May;28 Suppl 4:5-10.

Luce E, Steichen C, Allouche M, Messina A, Heslan JM, Lambert T, Weber A, Nguyen TH, Christophe O, Dubart-Kupperschmitt A. In vitro recovery of FIX clotting activity as a marker of highly functional hepatocytes in a hemophilia B iPSC model. Hepatology. 2022 Apr;75(4):866-880.

Magnani A, Semeraro M, Adam F, Booth C, Dupré L, Morris EC, Gabrion A, Roudaut C, Borgel D, Toubert A, Clave E, Abdo C, Gorochov G, Petermann R, Guiot M, Miyara M, Moshous D, Magrin E, Denis A, Suarez F, Lagresle C, Roche AM, Everett J, Trinquand A, Guisset M, Bayford JX, Hacein-Bey-Abina S,Kauskot A, Elfeky R, Rivat C, Abbas S, Gaspar HB, Macintyre E, Picard C, Bushman FD, Galy A, Fischer A, Six E, Thrasher AJ, Cavazzana M. Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome. Nat Med. 2022, 28, 71-80.

Manry J, Bastard P, Gervais A, Voyer TL, Rosain J, Philippot Q, Michailidis E, Hoffmann HH, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Haljasmägi L, Migaud M, Särekannu K, Maslovskaja J, de Prost N, Tandjaoui-Lambiotte Y, Luyt CE, Amador-Borrero B, Gaudet A, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier JC, Gentile S, Rosen L, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux PL, Sene D, Stepanian A, Mégarbane B, Triantafyllia V, Fekkar A, Heath J, Franco J, Anaya JM, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte O, Zhang Y, Snow A, Holland S, Biggs C, Moncada-Vélez M, Arias A, Lorenzo L, Boucherit S, Anglicheau D, Planas A, Haerynck F, Duvlis S, Nussbaum R, Ozcelik T, Keles S, Bousfiha A, Bakkouri JE, Ramirez-Santana C, Paul S, Pan-Hammarstrom Q, Hammarstrom L, Dupont A, Kurolap A, Metz C, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros L, Dominguez-Garrido E, Vidigal M, Zatz M, van de Beek D, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye S, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann N, Shcherbina A, Lau YL, Leung D, Coulongeat M, Marlet J, Koning R, Reyes L, Chauvineau-Grenier A, Venet F, Monneret G, Nussenzweig M, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer A, Kennelly S, Bourke N, Halwani R, Sharif-Askari F, Dorgham K, Sallette J, Mehlal-Sedkaoui S, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh D, Erikstrup C, Condino-Neto A, Prando C, Bondarenko A, Spaan A, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton R, Mane S, Anderson M, Boisson B, Béziat V, Zhang SY, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen TH, Rowen L, Mond J, Debette S, deLamballerie X, Burdet C, Bouadma L, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen P, Rodríguez-Gallego C, Piemonti L, Notarangelo L, Su H, Kisand K, Okada S, Puel A, Jouanguy E, Rice C, Tiberghien P, Zhang Q, Casanova JL, Abel L, Cobat A. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies. Res Sq. 2022 Jan 14;rs.3.rs-1225906.

McCafferty C, Cai T, Borgel D, Lasne D, Renolleau S, Vedrenne-Cloquet M, Bonnet D, Wu J, Zaw T, Bhatnagar A, Song X, Van Den Helm S, Letunica N, Attard C, Karlaftis V, Praporski S, Ignjatovic V, Monagle P. Pathophysiological pathway differences in children who present with COVID-19 ARDS compared to COVID -19 induced MIS-C. Nat Commun. 2022 May 2;13(1):2391.

Moine M, Vasse M, Jegaden S, Boufares O, Besson E, Dodille S, Jerome J, Bonan B, Ducasse V. AVK overdose in Covid-19 infected patients. Geriatr Psychol Neuropsychiatr Vieil. 2022 Feb 8.

Nguyen NAT, Auquier P, Beltran Anzola A, d’Oiron R, Biron-Andréani C, Lienhart A, Rauch A, Baumstarck K, Boucekine M, Milien V, Rosso-Delsemme N, Tabele C, Giraud N, Sannié T, Chambost H, Resseguier N; INTHEMO Study Group. Occupational integration of adults with severe haemophilia (INTHEMO): A study based on the FranceCoag registry. Haemophilia. 2022 Jul 20.

Pascreau T, Saller F, Bianchini EP, Lasne D, Bruneel A, Reperant C, Foulquier F, Denis CV, De Lonlay P, Borgel D. N-Glycosylation Deficiency Reduces the Activation of Protein C and Disrupts Endothelial Barrier Integrity. Thromb Haemost. 2022 Sep;122(9):1469-1478.

Pikta M, Vasse M, Smock KJ, Moser KA, van DM, Lejniece S, Szanto T, Bautista H, Nouadje G, Banys V. Establishing reference intervals for von Willebrand factor multimers. J Med Biochem. 2022 Feb 2;41(1):115-121.

Rugeri L, Harroche A, Repessé Y, Desprez D, Petesch BP, Chamouni P, Biron C, Frotscher B, Catovic H, Bracquart D, Martin C, Trossaërt M, Meunier S, d’Oiron R. Effectiveness of long-term prophylaxis using pdFVIII/VWF concentrate in patients with inherited von Willebrand disease. Eur J Haematol. 2022 Jul;109(1):109-117.

Sekkate S, Stoeklé HC, Mabro M, Billard D, Kennel T, Vasse M, Hervé C, Beuzeboc P. Letter comments on: Efficacy and safety of BNT162b2 vaccination in solid cancer patients receiving anti-cancer therapy – A single-centre prospective study: Interaction between lymphopenia and anti-SARS-CoV-2 antibodies after two injections of the Pfizer-BioNTech vaccine in patients with cancers treated by chemotherapy or immunotherapy. Eur J Cancer. 2022, 160, 282-284.

Sedzro JC, Adam F, Auditeau C, Bianchini E, De Carvalho A, Peyron I, Daramé S, Gandrille S, Thomassen S, Hackeng TM, Christophe OD, Lenting PJ, Denis CV, Borgel D, Saller F. Antithrombotic potential of a single-domain antibody enhancing the activated protein C-cofactor activity of protein S. J Thromb Haemost. 2022 Jul;20(7):1653-1664.

Stammler R, Ackermann F, Vasse M, Verrat A, David A, Horodyckid C, Gratieux J, Marroun I, Groh M, Roumier M, Paule R. Life-threatening chlorpromazine-induced acquired haemophilia A in a patient with a cavernous malformation involving the medulla oblongata. Rev Med Interne. 2022 Sep 5:S0248-8663(22)00631-2.

Tardieu L, Divard G, Lortholary O, Scemla A, Rondeau É, Accoceberry I, Agbonon R, Alanio A, Angoulvant A, Albano L, Attias P, Bellanger AP, Bertrand D, Bonhomme J, Botterel F, Bouvier N, Buchler M, Chouaki T, Crépin T, Durieux MF, Desoubeaux G, Doppelt G, Favennec L, Fekkar A, Fourdinier O, Frimat M, Gangneux JP, Garandeau C, Hasseine L, Hennequin C, Iriart X, Kamar N, Kaminski H, Kormann R, Lachaud L, Legendre C, Le Quintrec Donnette M, Leroy J, Levi C, Machouart M, Marx D, Menotti J, Moal V, Morio F, Mrozek N, Nicolas M, Poirier P, Peraldi MN, Poussot B, Ranque S, Rerolle JP, Sendid B, Snanoudj R, Tourret J, Vasse M, Vigneau C, Villard O, Mesnard L, Lanternier F, Rafat C. Cryptococcal Meningitis in Kidney Transplant Recipients: A Two-Decade Cohort Study in France. Pathogens. 2022 Jun 17;11(6):699.

Ternisien C, Lasne D, Grand F, Harzallah I, Jeanpierre E, Repesse Y, Ryman A, Sapin AF, Voisin S, Nougier C, Pouplard C; French study group on laboratory management of bleeding disorders (BIMHO Group-GFHT). Impact of aPTT reagents on measurement of a PEGylated recombinant FVIII (Adynovi ^® /Adynovate ^® ): A French multicentric field assay study. Int J Lab Hematol. 2022 Apr;44(2):e55-e59.

Testa S, Meijer P, Lasne D, Mullier F. Implementation of the new EUR IVD regulation and relation with ISO15189 accreditation: Guidance is urgently required for haemostasis testing. Int J Lab Hematol. 2022 Sep;44 Suppl 1:71-78.

Vallée A, Sveltlane D, Trichereau J, Neveu S, Fourn E, Majerholc C, Lesprit P, Mazaux L, Henintsoa SH, Matejczuk G, Vasse M, Zucman D. Electronic medical record alert increases HIV screening rates: the Foch hospital pilot POP-up project. BMC Health Serv Res. 2022 Jun 16;22(1):784.

Van Belle E, Debry N, Vincent F, Kuchcinski G, Cordonnier C, Rauch A, Robin E, Lassalle F, Pontana F, Delhaye C, Schurtz G, JeanPierre E, Rousse N, Casari C, Spillemaeker H, Porouchani S, Pamart T, Denimal T, Neiger X, Verdier B, Puy L, Cosenza A, Juthier F, Richardson M, Bretzner M, Dallongeville J, Labreuche J, Mazighi M, Dupont-Prado A, Staels B, Lenting PJ, Susen S. Cerebral Microbleeds During Transcatheter Aortic Valve Replacement: A Prospective Magnetic Resonance Imaging Cohort. Circulation. 2022 Aug 2;146(5):383-397.

Wohner N, Sebastian S, Muczynski V, Huskens D, de Laat B, de Groot PG, Lenting PJ. Osteoprotegerin modulates platelet adhesion to von Willebrand factor during release from endothelial cells. J Thromb Haemost. 2022 Mar;20(3):755-766.

Al Moosawi M, Iding A, Armstrong P, Chiasakul T, Campbell R, Casari C; ISTH Early Career Committee. Impact of the COVID-19 pandemic on education and clinical training. J Thromb Haemost. 2021, 19, 2099-2100.

Aymonnier K, Kawecki C, Arocas V, Boulaftali Y, Bouton MC. Serpins, New Therapeutic Targets for Hemophilia. Thromb Haemost . 2021 Mar;121(3):261-269

Barbon E, Kawecki C, Marmier S, Sakkal A, Collaud F, Charles S, Casari C, Christophe OD, Denis CV, Lenting PJ, Mingozzi F. Development of a dual hybrid AAV vector for endothelial-targeted expression of von Willebrand factor. Gene Ther. 2021 Jan 17. doi: 10.1038/s41434-020-00218-6.

Bareille M, Hardy M, Douxfils J, Roullet S, Lasne D, Levy JH, Stépanian A, Susen S, Frère C, Lecompte T, Mullier F. Viscoelastometric Testing to Assess Hemostasis of COVID-19: A Systematic Review. J Clin Med. 2021 Apr 16;10(8):1740.

Bastard P, Gervais A, Le Voyer T, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann HH, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Haljasmägi L, Migaud M, Särekannu K, Maslovskaja J, de Prost N, Tandjaoui-Lambiotte Y, Luyt CE, Amador-Borrero B, Gaudet A, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier JC, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux PL, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya JM, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs C, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, El Bakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, van de Beek D, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau YL, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Venet F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino-Neto A, Prando C, Bonradenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S; HGID Lab; COVID Clinicians; COVID-STORM Clinicians; NIAID Immune Response to COVID Group; NH-COVAIR Study Group; Danish CHGE; Danish Blood Donor Study; St. James’s Hospital; SARS CoV2 Interest group; French COVID Cohort Study Group; Imagine COVID-Group; Milieu Intérieur Consortium; CoV-Contact Cohort; Amsterdam UMC Covid-19; Biobank Investigators; COVID Human Genetic Effort; CONSTANCES cohort; 3C-Dijon Study; Cerba Health-Care; Etablissement du Sang study group, Anderson MS, Boisson B, Béziat V, Zhang SY, Vandreakos E, Hermine O, Pujol A, Peterson P, Mogensen TH, Rowen L, Mond J, Debette S, de Lamballerie X, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova JL. Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths. Sci Immunol. 2021, 6, eabl4340.

Beddek K, Raffin F, Borgel D, Saller F, Riccobono D, Bobe R, Boittin FX. TRPV4 channel activation induces the transition of venous and arterial endothelial cells toward a pro-inflammatory phenotype. Physiol Rep. 2021, 9, e14613.

Bianchini EP, Auditeau C, Razanakolona M, Vasse M, Borgel D. Serpins in Hemostasis as Therapeutic Targets for Bleeding or Thrombotic Disorders. Front Cardiovasc Med. 2021, 7:622778.

Bitan J, Bajolle F, Harroche A, Cannet P, Braems A, Taleb S, Bonnet D, Borgel D, Lasne D. A retrospective analysis of discordances between international normalized ratio (INR) self-testing and INR laboratory testing in a pediatric patient population. Int J Lab Hematol. 2021, 43, 1575-1584.

Borgel D, Chocron R, Grimaud M, Philippe A, Chareyre J, Brakta C, Lasne D, Bonnet D, Toubiana J, Angoulvant F, Desvages M, Renolleau S, Smadja DM, Oualha M. Endothelial Dysfunction as a Component of Severe Acute Respiratory Syndrome Coronavirus 2-Related Multisystem Inflammatory Syndrome in Children With Shock. Crit Care Med. 2021, 49, e1151-e1156.

Brun AL, Gence-Breney A, Trichereau J, Ballester MC, Vasse M, Chabi ML, Mellot F, Grenier PA. COVID-19 pneumonia: high diagnostic accuracy of chest CT in patients with intermediate clinical probability. Eur Radiol . 2021 Apr;31(4):1969-1977

Campioni M, Legendre P, Loubiere C, Lunghi B, Pinotti M, Christophe OD, Lenting PJ, Denis CV, Bernardi F, Casari C. In vivo modulation of a dominant-negative variant in mouse models of von Willebrand disease type 2A. J Thromb Haemost. 2021, 19, 139-146.

Capdevila L, Borgel D, Lasne D, Lacroix-Desmazes S, Desvages M, Delignat S, Bally C, Frenzel L, Harroche A. Reappearance of inhibitor in a tolerized patient with severe haemophilia A during FVIII-free emicizumab therapy. Haemophilia. 2021, 27, e581-e584.

Cardot Martin E, Renaux C, Catherinot E, Limousin L, Couderc LJ, Vasse M. Rapid identification of fungi from respiratory samples by Bruker Biotyper matrix-assisted laser desorption/ionisation time-of-flight using ID-FUNGI plates. Eur J Clin Microbiol Infect Dis. 2021, 40, 391-395.

Chabi ML, Dana O, Kennel T, Gence-Breney A, Salvator H, Ballester MC, Vasse M, Brun AL, Mellot F, Grenier PA. Automated AI-Driven CT Quantification of Lung Disease Predicts Adverse Outcomes in Patients Hospitalized for COVID-19 Pneumonia. Diagnostics (Basel). 2021, 11, 878.

Danlos FX, Grajeda-Iglesias C, Durand S, Sauvat A, Roumier M, Cantin D, Colomba E, Rohmer J, Pommeret F, Baciarello G, Willekens C, Vasse M, Griscelli F, Fahrner JE, Goubet AG, Dubuisson A, Derosa L, Nirmalathasan N, Bredel D, Mouraud S, Pradon C, Stoclin A, Rozenberg F, Duchemin J, Jourdi G, Ellouze S, Levavasseur F, Albigès L, Soria JC, Barlesi F, Solary E, André F, Pène F, Ackerman F, Mouthon L, Zitvogel L, Marabelle A, Michot JM, Fontenay M, Kroemer G. Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers. Cell Death Dis. 2021, 12, 258.

Denis CV, Susen S, Lenting PJ. Von Willebrand disease: What does the future hold? Blood. 2021, 137, 2299-2306.

Denorme F, Martinod K, Vandenbulcke A, Denis CV, Lenting PJ, Deckmyn H, Vanhoorelbeke K, De Meyer SF. The von Willebrand Factor A1 domain mediates thromboinflammation, aggravating ischemic stroke outcome in mice.  Haematologica . 2021 Mar 1;106(3):819-828

de Ponfilly GP, Lourtet-Hascoet J, Porcheret H, Cambau E, Le Monnier A, Jacquier H, Vasse M, Farfour E. Seasonal variations in blood culture numbers and time to positivity and potential impact of reducing incubation periods. Eur J Clin Microbiol Infect Dis. 2021, 40, 2087-2093.

d’Oiron R, O’Brien S, James AH. Women and girls with haemophilia: Lessons learned. Haemophilia. 2021, 27 Suppl 3, 75-81.

Dupont A, Rauch A, Staessens S, Moussa M, Rosa M, Corseaux D, Jeanpierre E, Goutay J, Caplan M, Varlet P, Lefevre G, Lassalle F, Bauters A, Faure K, Lambert M, Duhamel A, Labreuche J, Garrigue D, De Meyer SF, Staels B, Vincent F, Rousse N, Kipnis E, Lenting P, Poissy J, Susen S; Lille Covid Research Network (LICORNE). Vascular Endothelial Damage in the Pathogenesis of Organ Injury in Severe COVID-19. Arterioscler Thromb Vasc Biol. 2021, 41, 1760-1773.

Egot M, Lasne D, Poirault-Chassac S, Mirault T, Pidard D, Dreano E, Elie C, Gandrille S, Marchelli A, Baruch D, Rendu J, Fauré J, Flaujac C, Gratacap MP, Sié P, Gaussem P, Salomon R, Baujat G, Bachelot-Loza C. Role of oculocerebrorenal syndrome of Lowe (OCRL) protein in megakaryocyte maturation, platelet production and functions: a study in patients with Lowe syndrome. Br J Haematol. 2021, 192, 909-921.

Farfour E, Pascreau T, Jolly E, Zia-Chahabi S, Mazaux L, Vasse M. Spring is coming, where are the Respiratory Syncytial Virus and Influenza viruses? J Clin Virol. 2021 Jun;139:104824.

Farfour E, Asso-Bonnet M, Vasse M; SARS-CoV-2 Foch Hospital study group. The ID NOW COVID-19, a high-speed high-performance assay. Eur J Clin Microbiol Infect Dis. 2021, 40, 2041-2045.

Farfour E, Amiel C, Lecuru M, Zia-Chahabi S, Jolly E, Mazaux L, Simonin P, Cornily M, Catherineau A, Pascreau T, Vasse M. SARS-CoV-2 screening of asymptomatic health care workers: experience of a General hospital. Ann Biol Clin (Paris). 2021, 79, 325-330. 

Godon A, Tacquard CA, Mansour A, Garrigue D, Nguyen P, Lasne D, Testa S, Levy JH, Albaladejo P, Gruel Y, Susen S, Godier A; Gihp, the GFHT. Prevention of venous thromboembolism and haemostasis monitoring in patients with COVID-19: Updated proposals (April 2021): From the French working group on perioperative haemostasis (GIHP) and the French study group on thrombosis and haemostasis (GFHT), in collaboration with the French society of anaesthesia and intensive care (SFAR). Anaesth Crit Care Pain Med. 2021, 40, 100919.

Harroche A, Sefiane T, Desvages M, Borgel D, Lasne D, Casari C, Peyron I, Frenzel L, Chhun S, Lenting PJ, Bally C. Non-inhibitory antibodies inducing increased emicizumab clearance in a severe haemophilia A inhibitor patient. Haematologica. 2021, 106, 2287-2290.

Jeanne A, Sarazin T, Charlé M, Kawecki C, Kauskot A, Hedtke T, Schmelzer CEH, Martiny L, Maurice P, Dedieu S. Towards the Therapeutic Use of Thrombospondin 1/CD47 Targeting TAX2 Peptide as an Antithrombotic Agent. Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):e1-e17.

Lachaux J, Hwang G, Arouche N, Naserian S, Harouri A, Lotito V, Casari C, Lok T, Menager JB, Issard J, Guihaire J, Denis CV, Lenting PJ, Barakat AI, Uzan G, Mercier O, Haghiri-Gosnet AM. A compact integrated microfluidic oxygenator with high gas exchange efficiency and compatibility for long-lasting endothelialization. Lab Chip. 2021, 21, 4791-4804. 

Léguillier T, Favier R, Harroche A, Lasne D, Bachelot-Loza C, Borgel D, Boussaroque A, Pascreau T, Lallemant-Dudek P, Gkalea V, Haguet MC, Cormier-Daire V, Beaudeux JL, Monnot S, Lapillonne H, Baujat G, Forin V, Nivet-Antoine V. Assessing bleeding risk in 18 children with Osteogenesis imperfecta. Br J Haematol. 2021, 192, 785-788.

Martin EC, Cahen P, Yung T, Renaux C, Vasse M, Limousin L. [Monitoring of quality indicators for detection of mycobacteria in clinical laboratories]. Ann Biol Clin (Paris). 2021, 79, 96-98.

Mauser-Bunschoten EP, Kadir RA, Laan ETM, Elfvinge P, Haverman L, Teela L, Degenaar MEL, Fransen van de Putte DE, D’Oiron R, van Galen KPM. Managing women-specific bleeding in inherited bleeding disorders: A multidisciplinary approach. Haemophilia. 2021, 27, 436-469.

Moine M, Vasse M, Jegaden S, Boufares O, Besson E, Dodille S, Jerome J, Bonan B, Ducasse V. [VKA overdose in Covid-19 infected patients]. Geriatr Psychol Neuropsychiatr Vieil. 2021, 19, 392-400.

Ng BG, Sosicka P, Fenaille F, Harroche A, Vuillaumier-Barrot S, Porterfield M, Xia ZJ, Wagner S, Bamshad MJ, Vergnes-Boiteux MC, Cholet S, Dalton S, Dell A, Dupré T, Fiore M, Haslam SM, Huguenin Y, Kumagai T, Kulik M, McGoogan K, Michot C, Nickerson DA, Pascreau T, Borgel D, Raymond K, Warad D; University of Washington Center for Mendelian Genomics (UW-CMG), Flanagan-Steet H, Steet R, Tiemeyer M, Seta N, Bruneel A, Freeze HH. A mutation in SLC37A4 causes a dominantly inherited congenital disorder of glycosylation characterized by liver dysfunction. Am J Hum Genet. 2021, 108, 1040-1052. 

Pascreau T, Zia-Chahabi S, Zuber B, Tcherakian C, Farfour E, Vasse M. ADAMTS 13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19. Thromb Res. 2021, 204, 138-140.

Pascreau T, Tcherakian C, Zuber B, Farfour E, Vasse M, Lassalle P. A high blood endocan profile during COVID-19 distinguishes moderate from severe acute respiratory distress syndrome. Crit Care. 2021 May 6;25(1):166.

Pascreau T, Ballester MC, Van Dreden P, Zia-Chahabi S, Zuber B, Choucair J, Bironien R, Farfour E, Vasse M. The high frequency of anti-PF4/heparin antibodies in patients with COVID-19 is neither related to heparin treatment or to an increased incidence of thrombosis. Clin Chem Lab Med. 2021, 59, e405-e408.

Pascreau T, Tchikviladze M, Jolly E, Zia-Chahabi S, Lapergue B, Vasse M. Association of Protein Z with Prediabetes and Type 2 Diabetes . Endocrinol Metab (Seoul). 2021, 36, 1147-1148.

Pecnard S, Provot O, Levaique H, Bignon J, Askenatzis L, Saller F,Borgel D, Michallet S, Laisne MC, Lafanechère L, Alami M, Hamze A. Cyclic bridged analogs of isoCA-4: Design, synthesis and biological evaluation. Eur J Med Chem. 2021, 209, 112873.

Poirault-Chassac S, Nivet-Antoine V, Houvert A, Kauskot A, Lauret E, Lai-Kuen R, Dusanter-Fourt I, Baruch D. Mitochondrial dynamics and reactive oxygen species initiate thrombopoiesis from mature megakaryocytes. Blood Adv. 2021, 5, 1706-1718. 

Poulain M, Fossard C, Benammar A, Farfour E, Ranga S, Filali M, Vandame J, Pirtea P,  Vasse M, Racowsky C, Ayoubi JM. Validation of the French IVF guidelines during the COVID-19 pandemic. Reprod Biomed Online. 2021, 43, 491-493.

Rauch A, Paris C, Repesse Y, Branche J, D’Oiron R, Harroche A, Ternisien C, Castet S, Lebreton A, Pan-Petesch B, Volot F, Claeyssens S, Chamouni P, Gay V, Berger C, Desprez D, Falaise C, Biron Andreani C, Marichez C, Pradines B, Zawadzki C, Itzhar Baikian N, Borel-Derlon A, Goudemand J, Gerard R, Susen S; French Reference Center on von Willebrand Disease. Gastrointestinal bleeding from angiodysplasia in von Willebrand disease: improved diagnosis and outcome prediction using videocapsule on top of conventional endoscopy. J Thromb Haemost. 2021, 19, 380-386.

Razanakolona M, Adam F, Bianchini E, Saller F, Carvalho A, Diehl JL, Denis CV, Meziani F, Borgel D, Helms J, Vasse M. Anti-inflammatory Activity of the Protein Z-Dependent Protease Inhibitor. TH Open. 2021, 5, e220-e229.

Raynor A, Haouari W, Ng BG, Cholet S, Harroche A, Raulet-Bussian C, Lounis-Ouaras S, Vuillaumier-Barrot S, Pascreau T, Borgel D, Freeze HH, Fenaille F, Bruneel A. SLC37A4-CDG: new biochemical insights for an emerging congenital disorder of glycosylation with major coagulopathy. Clin Chim Acta. 2021, 521, 104-106.

Réau V, Vallée A, Terrier B, Plessier A, Abisror N, Ackermann F, Benainous R, Bohelay G, Chabi-Charvillat ML, Cornec D, Desbois AC, Faguer S, Freymond N, Gaillet A, Hamidou M, Killian M, Le Jeune S, Marchetti A, Meyer G, Osorio-Perez F, Panel K, Rautou PE, Rohmer J, Simon N, Tcherakian C, Vasse M, Zuelgaray E, Lefevre G, Kahn JE, Groh M. Venous thrombosis and predictors of relapse in eosinophil-related diseases. Sci Rep. 2021, 11, 6388.

Rossi E, Kauskot A, Saller F, Frezza E, Poirault-Chassac S, Lokajczyk A, Bourdoncle P, Saubaméa B, Gaussem P, Pericacho M, Bobe R, Bachelot-Loza C, Pasquali S, Bernabeu C, Smadja DM. Endoglin Is an Endothelial Housekeeper against Inflammation: Insight in ECFC-Related Permeability through LIMK/Cofilin Pathway. Int J Mol Sci. 2021 Aug 17;22(16):8837.

Roumier M, Paule R, Vallée A, Rohmer J, Ballester M, Brun AL, Cerf C, Chabi ML, Chinet T, Colombier MA, Farfour E, Fourn E, Géri G, Khau D, Marroun I, Ponsoye M, Roux A, Salvator H, Schoindre Y, Si Larbi AG, Tchérakian C,Vasse M, Verrat A, Zuber B, Couderc LJ, Kahn JE, Groh M, Ackermann F; Foch COVID-19 Study Group. Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score Analysis. J Clin Immunol. 2021, 41, 303-314.

Rugeri L, d’Oiron R, Harroche A, Proulle V, Mourey G, De Raucourt E, Desprez D, Baikian NI, Petesch BP, Borel-Derlon A, Combe S, Frotscher B, Hassoun A, Catovic H, Bracquart D, Trossaërt M. Effectiveness and safety of hFVIII/VWF concentrate (Voncento ^®) in patients with inherited von Willebrand disease requiring surgical procedures: the OPALE multicentre observational study. Blood Transfus. 2021, 19, 152-157.

Sanrattana W, Sefiane T, Smits S, van Kleef ND, Fens MH, Lenting PJ, Maas C, de Maat S. A reactive center loop-based prediction platform to enhance the design of therapeutic SERPINs. Proc Natl Acad Sci USA. 2021, 118, e2108458118.

Schell B, Desconclois C, Mariette X, Goujard C, Lenting PJ, Denis CV, Proulle V. Monoclonal gammopathy of clinical significance: in vivo demonstration of the anti-thrombotic effect of an acquired anti-thrombin antibody Haematologica. 2021, 106, 316-319.

Siguret V, Boissier E, De Maistre E, Gouin-Thibault I, James C, Lasne D , Mouton C, Godon A, Nguyen P, Lecompte T; Haemostasis and Thrombosis – French Society for Haematology). GFHT proposals on the practical use of argatroban – With specifics regarding vaccine-induced immune thrombotic thrombocytopaenia (VITT). Anaesth Crit Care Pain Med. 2021 Dec;40(6):100963.

Tardy-Poncet B, Montmartin A, Piot M, Alhenc-Gelas M, Nguyen P, Elalamy I, Greinacher A, Maistre E, Lasne D, Horellou MH, Le Gal G, Lecompte T, Tardy B, On Behalf Of The Gfht-Hit Study Group. Functional Flow Cytometric Assay for Reliable and Convenient Heparin-Induced Thrombocytopenia Diagnosis in Daily Practice. Biomedicines. 2021, 9, 332.

Tardy-Poncet B, de Maistre E, Pouplard C, Presles E, Alhenc-Gelas M, Lasne D, Horellou MH, Mouton C, Serre-Sapin A, Bauters A, Nguyen P, Mullier F, Perrin J, Le Gal G, Morange PE, Grunebaum L, Lillo-Le Louet A, Elalamy I, Gruel Y, Greinacher A, Lecompte T, Tardy B; GFHT-HIT study group. Heparin-induced thrombocytopenia: construction of a pre-test diagnostic score derived from the analysis of a prospective multinational database, with internal validation. J Thromb Haemost. 2021, 19, 1959-1972.

Vallée A, Vasse M, Mazaux L, Bonan B, Amiel C, Zia-Chahabi S, Chan-Hew-Wai A, Farfour E, Camps E, Touche P, Barret F, Parquin F, Zucman D, Fourn E. An Immunogenicity Report for the Comparison between Heterologous and Homologous Prime-Boost Schedules with ChAdOx1-S and BNT162b2 Vaccines. J Clin Med. 2021, 10, 3817.

van Galen K, Lavin M, Skouw-Rasmussen N, Fischer K, Noone D, Pollard D, Mauser-Bunschoten E, Khair K, Gomez K, van Loon E, Bagot CN, Elfvinge P, d’Oiron R, Abdul-Kadir R; European Haemophilia Consortium (EHC) and the European Association for Haemophilia and Allied Disorders (EAHAD). European principles of care for women and girls with inherited bleeding disorders. Haemophilia. 2021, 27, 837-847.

Vasse M, Ballester MC, Ayaka D, Sukhachev D, Delcominette F, Habarou F, Jolly E, Sukhacheva E, Pascreau T, Farfour É. Interest of the cellular population data analysis as an aid in the early diagnosis of SARS-CoV-2 infection. Int J Lab Hematol. 2021, 43, 116-122.

Vasse M, Zuber B, Goubeau L, Ballester MC, Roumier M, Delcominette F, Habarou F, Jolly E, Ackermann F, Cerf C, Farfour E, Pascreau T; SARS-CoV-2 Foch Hospital Study Group. A low level of CD16 ^pos monocytes in SARS-CoV-2 infected patients is a marker of severity. Clin Chem Lab Med. 2021, 59, 1315-1322.

Zirka G, Robert P, Tilburg J, Tishkova V, Maracle CX, Legendre P, van Vlijmen B, Alessi MC, Lenting PJ, Morange PE, Thomas GM. Impaired adhesion of neutrophils expressing Slc44a2/HNA-3b to VWF protects against NETosis under venous shear rate. Blood. 2021, 137, 2256-2266.

Barbon E, Ayme G, Mohamadi A, Ottavi JF, Kawecki C, Casari C, Verhenne S, Marmier S, van Wittenberghe L, Charles S, Collaud F, Denis CV, Christophe OD, Mingozzi F, Lenting PJ.
Single-domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without inhibitors. 
EMBO Mol Med. 2020 Apr 7;12(4):e11298

Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y, Dorgham K, Philippot Q, Rosain J, Béziat V, Manry J, Shaw E, Haljasmägi L, Peterson P, Lorenzo L, Bizien L, Trouillet-Assant S, Dobbs K, de Jesus AA, Belot A, Kallaste A, Catherinot E, Tandjaoui-Lambiotte Y, Le Pen J, Kerner G, Bigio B, Seeleuthner Y, Yang R, Bolze A, Spaan AN, Delmonte OM, Abers MS, Aiuti A, Casari G, Lampasona V, Piemonti L, Ciceri F, Bilguvar K, Lifton RP,Vasse M, Smadja DM, Migaud M, Hadjadj J, Terrier B, Duffy D, Quintana-Murci L, van de Beek D, Roussel L, Vinh DC, Tangye SG, Haerynck F, Dalmau D, Martinez-Picado J, Brodin P, Nussenzweig MC, Boisson-Dupuis S, Rodríguez-Gallego C, Vogt G, Mogensen TH, Oler AJ, Gu J, Burbelo PD, Cohen J, Biondi A, Bettini LR, D’Angio M, Bonfanti P, Rossignol P, Mayaux J, Rieux-Laucat F, Husebye ES, Fusco F, Ursini MV, Imberti L, Sottini A, Paghera S, Quiros-Roldan E, Rossi C, Castagnoli R, Montagna D, Licari A, Marseglia GL, Duval X, Ghosn J; HGID Lab; NIAID-USUHS Immune Response to COVID Group; COVID Clinicians; COVID-STORM Clinicians; Imagine COVID Group; French COVID Cohort Study Group; Milieu Intérieur Consortium; CoV-Contact Cohort; Amsterdam UMC Covid-19 Biobank; COVID Human Genetic Effort, Tsang JS, Goldbach-Mansky R, Kisand K, Lionakis MS, Puel A, Zhang SY, Holland SM, Gorochov G, Jouanguy E, Rice CM, Cobat A, Notarangelo LD, Abel L, Su HC, Casanova JL.
Auto-antibodies against type I IFNs in patients with life-threatening COVID-19.
Science. 2020, 370 : (6515):eabd4585.

Bataille P, Michaud V, Robert MP, Bekel L, Leclerc-Mercier S, Harroche A, Célérier C, Lasseaux E, Borgel D, Bremond-Gignac D, Bodemer C, Arveiler B, Hadj-Rabia S. Clinical variability and probable founder effect in oculocutaneous albinism type 7.
Clin Genet. 2020, Mar;97(3):527-528.

Calzavarini S, Prince-Eladnani R,Saller F, Bologna L, Burnier L, Brisset AC, Quarroz C, Reina Caro MD, Ermolayev V, Matsumura Y, Fernández JA, Hackeng TM, Griffin JH, Angelillo-Scherrer A.
Platelet protein S limits venous but not arterial thrombosis propensity by controlling coagulation in the thrombus.
Blood. 2020 May 28;135(22):1969-1982

Čechová A, Altassan R, Borgel D, Bruneel A, Correia J, Girard M, Harroche A, Kiec-Wilk B, Mohnike K, Pascreau T, Pawliński Ł, Radenkovic S, Vuillaumier-Barrot S, Aldamiz-Echevarria L, Couce ML, Martins EG, Quelhas D, Morava E, de Lonlay P, Witters P, Honzík T.
Consensus guideline for the diagnosis and management of mannose phosphate isomerase-congenital disorder of glycosylation. 
J Inherit Metab Dis. 2020, Jul;43(4):671-693. 

Chetrit A, Lechien JR, Ammar A, Chekkoury-Idrissi Y, Distinguin L, Circiu M, Saussez S, Ballester MC, Vasse M, Berradja N, Hans S, Carlier R, Edjlali M.
Magnetic resonance imaging of COVID-19 anosmic patients reveals abnormalities of the olfactory bulb: Preliminary prospective study.
J Infect . 2020 Nov;81(5):816-846.

Dubois MD, Pierre-Louis S, Rabout J, Denis CV, Christophe O, Susen S, Goudemand J, Boisseau P, Neviere R, Pierre-Louis O.
A Combination of Two Variants p. (Val510 =) and p. (Pro2145Thrfs * 5), Responsible for von Willebrand Disease Type 3 in a Caribbean Patient.
TH Open . 2020 Oct 27;4(4):e318-e321.

Delignat S, Rayes J, Dasgupta S, Gangadharan B, Denis CV, Christophe OD, Bayry J, Kaveri SV, Lacroix-Desmazes S.
Removal of mannose-ending glycan at Asn 2118 abrogates FVIII presentation by human monocyte-derived dendritic cells.
Frontiers in Immunology. 2020, Mar 26;11:393.

Denorme F, Martinod K, Vandenbulcke A, Denis CV, Lenting PJ, Deckmyn H, Vanhoorelbeke K, De Meyer SF.
The von Willebrand Factor A1 domain mediates thromboinflammation, aggravating ischemic stroke outcome in mice. 
Haematologica . 2020 Feb 27;haematol.2019.241042.

Farfour E, Ballester MC, Lecuru M, Verrat A, Imhaus E, Mellot F, Karnycheff F, Vasse M, Cerf C, Lesprit P.
COVID-19: before stopping specific infection prevention and control measures, be sure to exclude the diagnosis.
J Hosp Infect. 2020, Jun;105(2):375-376.  (Cases report)

Farfour E, Degand N, Muggeo A, Marcelino P, Vasse M, Guillard T.
Accurate identification of S. pneumoniae using MALDI-TOF mass spectrometry, still a challenge for clinical laboratories?
Eur J Clin Microbiol Infect Dis. 2020, Jan;39(1):209-211. (Letter)

Farfour E, Jolly E, Pascreau T, Asso-Bonnet M, Mazaux L, Vasse M; SARS-CoV-2 Foch Hospital study group.
SARS-CoV-2 RT-PCR: at least 2 viral targets are needed.
Infect Dis (Lond). 2020, Aug;52(8):583-584.

Farfour E, Lecuru M, Dortet L, Guen ML, Cerf C, Karnycheff F, Bonnin RA,Vasse M, Lesprit P; SARS-CoV-2 Hospital Foch study group.
Carbapenemase-producing Enterobacterales outbreak: another dark side of COVID-19.
Am J Infect Control. 2020 Dec;48(12):1533-1536.

Farfour E, Lesprit P, Visseaux B, Pascreau T, Jolly E, Houhou N, Mazaux L, Asso-Bonnet M, Vasse M; SARS-CoV-2 Foch Hospital study group.
The Allplex 2019-nCoV (Seegene) assay: which performances are for SARS-CoV-2 infection diagnosis?
Eur J Clin Microbiol Infect Dis. 2020 May 28

Farfour E, Mellot F, Lesprit P,Vasse M; SARS-CoV-2 Foch hospital study group.
SARS-CoV-2 RT-PCR and Chest CT, two complementary approaches for COVID-19 diagnosis.
Jpn J Radiol. 2020, Dec;38(12):1209-1210. (Letter)

Farfour E, Picard C, Beaumont L, Lesprit P, Ballester MC, Ackermann F, Galliot R, Colin de Verdiere S, Cerf C,Vasse M; Sars-Cov-2 Foch Hospital study group.
COVID-19 in lung-transplanted and cystic fibrosis patients: Be careful.
J Cyst Fibros. 2020, May;19(3):e16-e17. (Case report)

Farfour E, Roux A, Ballester M, Gagneur L, Renaux C, Jolly E, Vasse M.
Improved performances of the second generation of the ID NOW influenza A&B 2® and comparison with the GeneXpert®.
Eur J Clin Microbiol Infect Dis . 2020 Sep;39(9):1681-1686.

Feng M, Elaïb Z, Borgel D, Denis CV, Adam F, Bryckaert M, Rosa JP, Bobe R.
NAADP/SERCA3-Dependent Ca²⁺ Stores Pathway Specifically Controls Early Autocrine ADP Secretion Potentiating Platelet Activation.
Circ Res . 2020 Sep 11;127(7):e166-e183

Ferrière S, Peyron I, Christophe OD, Kawecki C, Casari C, Muczynski V, Nathwani AC, Kauskot A, Lenting PJ, Denis CV.
A Hemophilia A Mouse Model for the in Vivo Assessment of Emicizumab Function
Blood . 2020 Aug 6;136(6):740-748.

Fiore M, De Thoré C, Randrianaivo-Ranjatoelina H, Baas MJ, Jacquemont ML, Dreyfus M,Lavenu-Bombled C, Li R, Gachet C, Dupuis A, Lanza F.
High prevalence of the natural Asn89Asp mutation in the GP1BB gene associated with Bernard-Soulier syndrome in French patients from the genetic isolate of Reunion Island.
Br J Haematol. 2020, May;189(3):e67-e71.

Gendron N, Chocron R, Billoir P, Brunier J, Camoin-Jau L, Tuffigo M, Faille D, Teissandier D, Gay J, de Raucourt E, Suner L, Bonnet C, Martin AC, Lasne D, Ladhari C, Lebreton A, Bertoletti L, Ajzenberg N, Gaussem P, Morange PE, Le Cam Duchez V, Viallon A, Roy PM, Lillo-le Louët A, Smadja DM.  Dabigatran Level Before Reversal Can Predict Hemostatic Effectiveness of Idarucizumab in a Real-World Setting. Front Med (Lausanne). 2020, 7, 599626.

Girard M, Douillard C, Debray D, Lacaille F, Schiff M, Vuillaumier-Barrot S, Dupré T, Fabre M, Damaj L, Kuster A, Torre S, Mention K, McLin V, Dobbelaere D, Borgel D, Bauchard E, Seta N, Bruneel A, De Lonlay P.
Long term outcome of MPI-CDG patients on D-mannose therapy.
J Inherit Metab Dis. 2020, 43 :1360-1369.

Gruel Y, De Maistre E, Pouplard C, Mullier F, Susen S, Roullet S, Blais N, Le Gal G, Vincentelli A, Lasne D, Lecompte T, Albaladejo P, Godier A; Members of the French Working Group on Perioperative Haemostasis Groupe d’intérêt en hémostase périopératoire GIHP.
Diagnosis and management of heparin-induced thrombocytopenia.
Anaesth Crit Care Pain Med. 2020, Apr;39(2):291-310.

Gruel Y, Vayne C, Rollin J, Weber P, Faille D, Bauters A, Macchi L, Alhenc-Gelas M, Lebreton A, De Maistre E, Voisin S, Gouilleux-Gruart V, Perrin J, Tardy-Poncet B, Elalamy I, Lavenu-Bombled C, Mouton C, Biron C, Ternisien C, Nedelec-Gac F, Duchemin J, De Raucourt E, Gouin-Thibault I, Rugeri L, Tardy B, Giraudeau B, Bejan-Angoulvant T, Pouplard C.
Comparative analysis of a French prospective series of 144 patients with Heparin-Induced Thrombocytopenia (FRIGTIH) and the literature.
Thromb. Haemost. 2020, Jul;120(7):1096-1107. 

Heaney J, Ackermann F, Paunet-Bobo M, Mehlal S, Jolly E, Hachem J, Védrenne A,Vasse M.
Evaluation of two serum free light chain quantitation methods, Freelite and Seralite, in the clinical laboratory with a view to switching immunoassay.
Clin Chim Acta . 2020 Nov;510:235-241.

Jeanpierre E, Pouplard C, Lasne D, Le Cam Duchez V, Eschwege V, Flaujac C, Galinat H, Harzalla I, Proulle V, Smahi M, Sobas F, Stepina N, Toulon P, Voisin S, Ternisien C, Nougier C; French Study Group on the Biology of Hemorrhagic Diseases (the BIMHO group).
Factor VIII and IX assays for post-infusion monitoring in hemophilia patients: guidelines from the French BIMHO group (GFHT). 
Eur J Haematol. 2020, Aug;105(2):103-115.

Kawecki C, Aymonnier K, Ferrière S, Venisse L, Arocas V, Boulaftali Y, Christophe OD, Lenting PJ, Bouton MC, Denis CV.
Development and characterization of single-domain antibodies neutralizing protease nexin-1 as tools to increase thrombin generation.
J Thromb Haemost . 2020 Sep;18(9):2155-2168.

Kulkarni K, Chiasakul T, Riva N, Eslick R, Casari C; ISTH Early Career Committee. Exciting times for the ISTH early career professionals. J Thomb Haemost. 2020, 18, 2437-2438.

Lasne D, Pascreau T, Darame S, Bourrienne M-C, Tournoux P, Philippe A, Ziachahabi S, Suarez F, Marcais A, Dupont A, Denis CV, Kauskot A, Borgel D.
Measuring beta-galactose exposure on platelets: standardization and healthy reference values.
Res Pract Thromb Haemost. 2020 Jun 2;4(5):813-822.

Lasne D, Drouet L, Schved JF, Gruel Y; Groupe de relecture.
GFHT proposals for management of discordance between the International normalized ratio measured in the laboratory and by self-testing
Ann Biol Clin (Paris) . 2020 Dec 1;78(6):655-664.

Lenting PJ.
Laboratory monitoring of hemophilia A treatments: new challenges.
Blood Adv. 2020, May 12;4(9):2111-2118. 

López-Gálvez R, de la Morena-Barrio ME, López-Lera A, Pathak M, Miñano A, Serrano M, Borgel D, Roldán V, Vicente V, Emsley J, Corral J. Factor XII in PMM2-CDG patients: role of N-glycosylation in the secretion and function of the first element of the contact pathway. Orphanet J Rare Dis. 2020 Oct 9;15(1):280.

Michels A, Dwyer CN, Mewburn J, Nesbitt K, Kawecki C, Lenting P, Swystun LL, Lillicrap D.
von Willebrand Factor Is a Critical Mediator of Deep Vein Thrombosis in a Mouse Model of Diet-Induced Obesity.
Arterioscler Thromb Vasc Biol. 2020 Dec;40(12):2860-2874. 

Nougier C, Jeanpierre E, Ternisien C, Proulle V, Hezard N, Pouplard C, Lasne D; Working Group on Biology of Haemorrhagic Disorders (BIMHO, under the aegis of GFHT).
Emicizumab treatment: Impact on coagulation tests and biological monitoring of haemostasis according to clinical situations (BIMHO group proposals).
Eur J Haematol . 2020 Dec;105(6):675-681.

Ortillon J, Hézard N, Belmokhtar K, Kawecki C, Terryn C, Fritz G, Kauskot A, Schmidt AM, Rieu P, Nguyen P, Maurice P, Touré F.
Receptor for Advanced Glycation End Products is Involved in Platelet Hyperactivation and Arterial Thrombosis during Chronic Kidney Disease.
Thromb Haemost. 2020 Sep;120(9):1300-1312.

Pavani G, Laurent M, Fabiano A, Cantelli E, Sakkal A, Corre G, Lenting PJ, Concordet J-P, Toueille M, Miccio A, Amendola M.
Ex vivo editing of human hematopietic stem cells for erythroid expression of therapeutic proteins.
Nat Commun . 2020 Jul 29;11(1):3778.

Peyron I, Kizlik-Masson C, Dubois M-D, Atsou S, Ferrière S, Denis CV, Lenting PJ, Casari C, Christophe OD.
Camelid-derived single chain antibodies in hemostasis: mechanistic, diagnostic and therapeutic applications.
Res Pract Thromb Haemost. 2020 Sep 9;4(7):1087-1110.

Rauch A, Dupont A, Goutay J, Caplan M, Staessens S, Moussa M, Jeanpierre E, Corseaux D, Lefevre G, Lassalle F, Faure K, Lambert M, Duhamel A, Labreuche J, Garrigue D, De Meyer SF, Staels B, Van Belle E, Vincent F, Kipnis E, Lenting PJ, Poissy J, Susen S; Lille COVID Research Network (LICORNE); Members of the LICORNE Scientific Committee.
Endotheliopathy Is Induced by Plasma From Critically Ill Patients and Associated With Organ Failure in Severe COVID-19.
Circulation . 2020 Nov 10;142(19):1881-1884.

Rauch A, Labreuche J, Lassalle F, Goutay J, Caplan M, Charbonnier L, Rohn A, Jeanpierre E, Dupont A, Duhamel A, Faure K, Lambert M, Kipnis E, Garrigue D, Lenting PJ, Poissy J, Susen S.
Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID-19.
J Thromb Haemost . 2020 Nov;18(11):2942-2953.

Receveur N, Nechipurenko D, Knapp Y, Yakusheva A, Maurer E, Denis CV, Lanza F, Panteleev M, Gachet C, Mangin PH.
Shear rate gradients promote a bi-phasic thrombus formation on weak adhesive proteins, such as fibrinogen in a VWF-dependent manner.
Haematologica. 2020 Nov 14;105(10):2471-2483.

Russick J, Delignat S, Milanov P, Christophe O, Boros G, Denis CV, Lenting PJ, Kaveri SV, Lacroix-Desmazes S.
Correction of bleeding in experimental severe hemophilia A by systemic delivery of factor VIII-encoding mRNA. 
Haematologica. 2020 Apr;105(4):1129-1137

Sims MC, Mayer L, Collins J, Bariana T, Megy K, Lavenu-Bombled C, Seyres D, Kollipara L, Burden F, Greene D, Lee D, Rodriguez-Romera A, Alessi MC, Astle WJ, Bahou W, Bury L, Chalmers E, Da Silva R, De Candia E, Deevi SVV, Farrow S, Gomez K, Grassi L, Greinacher A, Gresele P, Hart DP, Hurtaud MF, Kelly A, Kerr R, Le Quellec S, Leblanc TM, Leinøe EB, Mapeta RP, McKinney H, Michelson AD, Morais S, Nugent DJ, Papadia S, Park SJ, Pasi J, Podda GM, Poon MC, Reed R, Sekhar M, Shalev H, Sivapalaratnam S, Steinberg-Shemer O, Stephens JC, Tait RC, Turro E, Wu JK, Zieger BMH, BioResource N, Kuijpers TW, Whetton AD, Sickmann A, Freson K, Downes K, Erber W, Frontini M, Nurden P, Ouwehand WH, Favier R, Guerrero JA.
Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome.
Blood . 2020 Oct 22;136(17):1956-1967.

Susen S, Rauch A, Lenting P. Coagulation markers are independent predictors of increased oxygen requirements and thrombosis in COVID-19: Response from Original Authors Susen, et al. J Thromb Haemost. 2020, 18, 3385-3386.

Tiede A, Collins P, Knoebl P, Teitel J, Kessler C, Shima M, Di Minno G, d’Oiron R, Salaj P, Jiménez-Yuste V, Huth-Kühne A, Giangrande P.
International recommendations on the diagnosis and treatment of acquired hemophilia A.
Haematologica. 2020 Jul;105(7):1791-1801.

van den Berg HM, Mancuso ME, Königs C, D’Oiron R, Platokouki H, Mikkelsen TS, Motwani J, Nolan B, Santagostino E; European Pediatric Network for Haemophilia Management (PedNet).
ITI Treatment is not first-choice treatment in children with hemophilia A and low-responding inhibitors: evidence from a PedNet study.
Thromb Haemost . 2020 Aug;120(8):1166-1172.

van Galen KPM, Lavin M, Skouw-Rasmussen N, Ivanova E, Mauser-Bunschoten E, Punt M, Romana G, Elfvinge P, d’Oiron R, Abdul-Kadir R.
Clinical management of woman with bleeding disorders: A survey among European haemophilia treatment centres.
Haemophilia . 2020 Jul;26(4):657-662.

Vasse M, Francois D, Van Dreden P, de Mazancourt P.
Different sensitivity of von Clauss reagents for the diagnosis of dysfibrinogenemia.
Eur J Haematol, 2020 Jan;104(1):70-71.

Vedrenne A, Devin C, Delcominette F, Habarou F, Vasse M.
Detection of monoclonal B-lymphocytosis: interest of cellular population data and CytoDiff™ analysis.
Clin Chem Lab Med. 2020, Feb 25;58(3):e83-e86.

Altassan R, Péanne R, Jaeken J, Barone R, Bidet M, Borgel D, Brasil S, Cassiman D, Cechova A, Coman D, Corral J, Correia J, de la Morena-Barrio ME, de Lonlay P, Dos Reis V, Ferreira CR, Fiumara A, Francisco R, Freeze H, Funke S, Gardeitchik T, Gert M, Girad M, Giros M, Grünewald S, Hernández-Caselles T, Honzik T, Hutter M, Krasnewich D, Lam C, Lee J, Lefeber D, Marques-de-Silva D, Martinez AF, Moravej H, Õunap K, Pascoal C, Pascreau T, Patterson M, Quelhas D, Raymond K, Sarkhail P, Schiff M, Seroczyńska M, Serrano M, Seta N, Sykut-Cegielska J, Thiel C, Tort F, Vals MA, Videira P, Witters P, Zeevaert R, Morava E.
International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: Diagnosis, treatment and follow up.
J Inherit Metab Dis. 2019 Jan;42(1):5-28. 

Aymonnier K, Kawecki C, Venisse L, Boulaftali Y, Christophe OD, Lenting PJ, Arocas V, de Raucourt E,Denis CV,Bouton MC.
Targeting Protease Nexin-1, a natural anticoagulant serpin, to control bleeding and improve hemostasis in hemophilia.
Blood. 2019 Nov 7;134(19):1632-1644

Borgel D, Bianchini E, Lasne D, Pascreau T, Saller F.
Inflammation in deep vein thrombosis: a therapeutic target? 
Hematology. 2019 Dec;24(1):742-750

Cardot Martin E, Martinucci P, Limousin L, Cahen P, Farfour E, Vasse M, Mathonnet D.
Contribution and evolution of blood culture quality indicators.
Ann Biol Clin (Paris). 2019 Jun 1;77(3):331-338. 

Cossutta M, Darche M, Carpentier G, Houppe C, Ponzo M, Raineri F, Vallée B, Gilles ME, Villain D, Picard E, Casari C, Denis C, Paques M, Courty J, Cascone I.
Weibel-Palade Bodies Orchestrate Pericytes During Angiogenesis. 
Arterioscler Thromb Vasc Biol. 2019, 39, 1843-1858.

Donada A, Balayn N, Sliwa D, Lordier L, Ceglia V, Baschieri F, Goizet C, Favier R, Tosca L, Tachdjian G, Denis CV, Plo I, Vainchenker W, Debili N, Rosa JP, Bryckaert M, Raslova H.
Increased RhoA activity due to a disrupted filamin A/αIIbβ3 interaction induces macrothrombocytopenia. 
Blood, 2019, 133, 1778-1788.

Dupont A, Soukaseum C, Cheptou M, Adam F, Nipoti T, Lourenco-Rodrigues MD, Legendre P, Proulle V, Rauch A, Kawecki C, Bryckaert M, Rosa JP, Paris C, Ternisien C, Boisseau P, Goudemand J, Borgel D, Lasne D, Maurice P, Lenting PJ, Denis CV, Susen S, Kauskot A.
Relevance of platelet desialylation and thrombocytopenia in type 2B von Willebrand disease: preclinical and clinical evidence. 
Haematologica. 2019 Feb 28. pii: haematol.2018.206250.

Elaïb Z, Lopez JJ, Coupaye M, Zuber K, Becker Y, Kondratieff A, Repérant C, Pépin M, Salomon L, Teillet F, Msika S, Denis CV, de Prost D, Rosa JP, Bobe R, Stépanian A.
Platelet Functions are Decreased in Obesity and Restored after Weight Loss: Evidence for a Role of the SERCA3-Dependent ADP Secretion Pathway. 
Thromb Haemost. 2019 Mar;119(3):384-396.

Farfour E, Henry A, Razillard A, Cardot E, Limousin L, Cahen P, Jolly E, Vasse M, Mathonnet D.
Rapid identification of Escherichia coli colonies from clinical sample inoculated on CHROMagar Orientation media (Becton Dickinson).
Ann Biol Clin (Paris). 2019 Jun 1;77(3):350-352.

Farfour E, Limousin L, Henry A, Cardot E, Karnycheff F, Lecointe D, Jolly E, Vasse M, Mathonnet D.
Evaluation of the environmental contamination in microbiology Which strategy to adopt? 
Ann Biol Clin (Paris). 2019 Apr 1;77(2):225-228. 

Farfour E, Si Larbi AG, Cardot E, Limousin L, Mathonnet D, Cahen P, Vasse M, Lesprit P.
Impact of rapid diagnostic tests on the management of patients presenting with Enterobacteriaceae bacteremia.
Med Mal Infect. 2019 May;49(3):202-207. 

Ferrière S, Lenting PJ.
Antibodies in the Treatment of Haemophilia A-A Biochemical Perspective.
Hamostaseologie. 2019, 39, 36-41. 

Ferrière S, Kawecki C, Ottavi JF, Denis CV, Kauskot A, Christophe OD, Lenting PJ. 
A single-domain antibody that blocks factor VIIa activity in the absence but not presence of tissue factor. 
J Thromb Haemost. 2019 Dec;17(12):2035-2046

Gavrel M, Rafowicz A, d’Oiron R, Franchi-Abella S, Lambert T, Adamsbaum C.
Imaging features of atypical bleeds in young patients with hemophilia. 
Diagn Interv Imaging. 2019, 100, 135-145.

Giorni C, Pezzella C, Bojan M, Ricci Z, Pouard P, Raisky O, Tourneur L, La Salvia O, Favia I, Borgel D, Cogo P, Carotti A, Lasne D.
Impact of Heparin- or Nonheparin-Coated Circuits on Platelet Function in Pediatric Cardiac Surgery.
Ann Thorac Surg. 2019 Apr;107(4):1241-1247.

Godier A, Garrigue D, Lasne D, Fontana P, Bonhomme F, Collet JP, de Maistre E, Ickx B, Gruel Y, Mazighi M, Nguyen P, Vincentelli A, Albaladejo P, Lecompte T.
Management of antiplatelet therapy for non elective invasive procedures of bleeding complications: proposals from the French working group on perioperative haemostasis (GIHP), in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR).
Anaesth Crit Care Pain Med. 2019 Jun;38(3):289-302.

Godier A, Garrigue D, Lasne D, Fontana P, Bonhomme F, Collet JP, de Maistre E, Ickx B, Gruel Y, Mazighi M, Nguyen P, Vincentelli A, Albaladejo P, Lecompte T; French Working Group on Perioperative Haemostasis (GIHP).
Management of antiplatelet therapy for non-elective invasive procedures or bleeding complications: Proposals from the French Working Group on Perioperative Haemostasis (GIHP) and the French Study Group on Thrombosis and Haemostasis (GFHT), in collaboration with the French Society for Anaesthesia and Intensive Care (SFAR).
Arch Cardiovasc Dis. 2019 Mar;112(3):199-216.

Gruel Y, Kizlik-Masson C, Lenting P.
Therapeutic antibodies in hemostasis. From the past to the future. 
Med Sci (Paris). 2019 Dec;35(12):1022-1025.

Guy A, Gourdou-Latyszenok V, Le Lay N, Peghaire C, Kilani B, Vieira Dias J, Duplaa C, Renault MA, Denis C, Villeval JL, Boulaftali Y, Jandrot-Perrus M, Couffinhal T, James C.
Vascular endothelial cell expression of JAK2V617F is sufficient to promote a pro-thrombotic state due to increased P-selectin expression. 
Haematologica. 2019 Jan;104(1):70-81.

Lasne D, Pouplard C, Nougier C, Eschwege V, Le Cam Duchez V, Proulle V, Smahi M, Harzallah I, Voisin S, Toulon P, Sobas F, Galinat H, Flaujac C, Ternisien C, Jeanpierre E; groupe d’études de la biologie des maladies hémorragiques du Groupe français d’études de l’hémostase et la thrombose.
Factor VIII assays in treated hemophilia A patients.
Ann Biol Clin (Paris). 2019 Feb 1;77(1):53-65.

Muczynski V, Verhenne S, Casari C, Chérel G, Panicot-Dubois L, Gueguen P, Trossaert M, Dubois C, Lenting PJ, Denis CV, Christophe OD.
A Thrombin-Activatable Factor X Variant Corrects Hemostasis in a Mouse Model for Hemophilia A. 
Thromb Haemost. 2019 Dec;119(12):1981-1993.

Makris M, Iorio A, Lenting PJ.
Emicizumab and thrombosis: The story so far. 
J Thromb Haemost. 2019 Aug;17(8):1269-1272.

Pascreau T, de la Morena-Barrio ME, Lasne D, Serrano M, Bianchini E, Kossorotoff M, Boddaert N, Bruneel A, Seta N, Vicente V, de Lonlay P, Corral J, Borgel D. 
Elevated thrombin generation in patients with congenital disorder of glycosylation and combined coagulation factor deficiencies. 
J Thromb Haemost. 2019 Nov;17(11):1798-1807 

Perrier-Cornet A, Philippe A, Lambert T, d’Oiron R, Rafowicz A, Lavenu-Bombled C, Combe S, Gillibert A, 
Proulle V. FVIII dosages in persons with haemophilia A treated with extended half-life products: From local biology to optimized patient management.
Haemophilia. 2019 Nov;25(6):e361-e363

Picard V, Guitton C, Thuret I, Rose C, Bendelac L, Ghazal K, Aguilar-Martinez P, Badens C, Barro C, Bénéteau C, Berger C, Cathébras P, Deconinck E, Delaunay J, Durand JM, Firah N, Galactéros F, Godeau B, Jaïs X, de Jaureguiberry JP, Le Stradic C, Lifermann F, Maffre R, Morin G, Perrin J, Proulle V, Ruivard M, Toutain F, Lahary A, Garçon L.
Clinical and biological features in PIEZO1-hereditary xerocytosis and Gardos-channelopathy: A retrospective series of 126 patients.
Haematologica. 2019 Aug;104(8):1554-1564

Popovic B, Zannad F, Louis H, Clerc-Urmès I, Lakomy C, Gibot S, Denis CV, Lacolley P, Regnault V.
Endothelial-driven increase in plasma thrombin generation characterising a new hypercoagulable phenotype in acute heart failure. 
Int J Cardiol. 2019 Jan 1;274:195-201.

Pouplard C, Jeanpierre E, Lasne D, Le Cam Duchez V, Eschwege V, Flaujac C, Galinat H, Harzallah I, Proulle V, Smahi M, Sobas F, Ternisien C, Toulon P, Voisin S, Nougier C; groupe d’études de la biologie des maladies hémorragiques du Groupe français d’études de l’hémostase et la thrombose.
Factor IX assays in treated hemophilia B patients.
Ann Biol Clin (Paris). 2019 Feb 1;77(1):41-52. 

Proulle V, Strassel C, Perrault C, Baas MJ, Moog S, Mangin P, Nurden P, Nurden A, Adam F, Bryckaert M, Kauskot A, Li R, Lanza F.
A novel missense mutation in a leucine-rich repeat of GPIbα in a Bernard-Soulier variant reduces shear-dependent adherence on von Willebrand factor. 
Br J Haematol. 2019. Sep;186(6):e184-e187.

Rosa JP, Raslova H, Bryckaert M.
Filamin A: key actor in platelet biology.
Blood. 2019 Oct 17;134(16):1279-1288

Schneppenheim R, Hellermann N, Brehm MA, Klemm U, Obser T, Huck V, Schneider SW, Denis CV, Tischer A, Auton M, März W, Xu ER, Wilmanns M, Zotz RB.
The von Willebrand factor Tyr2561 allele is a gain-of-function variant and a risk factor for early myocardial infarction.
Blood. 2019 Jan 24;133(4):356-365.

Stoffman J, Andersson NG, Branchford B, Batt K, D’Oiron R, Escuriola Ettingshausen C, Hart DP, Jiménez Yuste V, Kavakli K, Mancuso ME, Nogami K, Ramírez C, Wu R.
Common themes and challenges in hemophilia care: a multinational perspective. 
Hematology. 2019 Dec;24(1):39-48.

Susen S, Gruel Y, Godier A, Harroche A, Chambost H, Lasne D, Rauch A, Roullet S, Fontana P, Goudemand J, de Maistre E, Chamouard V, Wibaut B, Albaladejo P, Négrier C.
Management of bleeding and invasive procedures in haemophilia A patients with inhibitor treated with emicizumab (Hemlibra® ): Proposals from the French network on inherited bleeding disorders (MHEMO), the French Reference Centre on Haemophilia, in collaboration with the French Working Group on Perioperative Haemostasis (GIHP).
Haemophilia. 2019 Sep;25(5):731-737

Van Belle E, Vincent F, Rauch A, Casari C, Jeanpierre E, Loobuyck V, Rosa M, Delhaye C, Spillemaeker H, Paris C, Debry N, Verdier B, Vincentelli A, Dupont A, Lenting PJ, Susen S.
von Willebrand Factor and Management of Heart Valve Disease: JACC Review Topic of the Week. 
J Am Coll Cardiol. 2019 Mar 12;73(9):1078-1088.

Vidal C, Moulin F, Nassif X, Galmiche L, Borgel D, Charbit A, Picard C, Mira JP, Lortholary O, Jamet A, Toubiana J.
Fulminant arterial vasculitis as an unusual complication of disseminated staphylococcal disease due to the emerging CC1 methicillin-susceptible Staphylococcus aureus clone: a case report.
BMC Infect Dis. 2019 Apr 3;19(1):302. 

Witters P, Honzik T, Bauchart E, Altassan R, Pascreau T, Bruneel A, Vuillaumier S, Seta N, Borgel D, Matthijs G, Jaeken J, Meersseman W, Cassiman D, Pascale de L, Morava E.
Long-term follow-up in PMM2-CDG: are we ready to start treatment trials?
Genet Med. 2019 May;21(5):1181-1188. 

Xu ER, von Bülow S, Chen PC, Lenting PJ, Kolšek K, Aponte-Santamaría C, Simon B, Foot J, Obser T, Schneppenheim R, Gräter F, Denis CV, Wilmanns M, Hennig J.
Structure and dynamics of the platelet integrin-binding C4 domain of von Willebrand factor. 
Blood. 2019 Jan 24;133(4):366-376. 

Adam F, Kauskot A, Kurowska M, Goudin N, Munoz I,Bordet J-C, Huang J-D, Bryckaert M, Fischer A, Borgel D, de Saint Basile G, Christophe O,Ménasché G.
Kinesin-1 is a new actor involved in platelet secretion and thrombus stability. 
Arterioscler Thromb Vasc Biol. 2018 ; 38:1037-1051

Amedro P, Bajolle F, Bertet H, Cheurfi R, Lasne D, Nogue E, Auquier P, Picot MC, Bonnet D.
Quality of life in children participating in a non-selective INR self-monitoring VKA-education programme.
Arch Cardiovasc Dis. 2018, 111:180-188.

Andriamandimbisoa TH, Kahn JE, Bourdain F, François D, Vasse M.
High frequency of anti-protein Z antibodies in patients with anticardiolipin antibodies.
Immunobiology. 2018 Dec;223(12):772-776. 

Bergmeier W, Antoniak S, Conway EM, Denis CV, George LA, Isermann B, Key NS, Krishnaswamy S, Lam WA, Lillicrap D, Liu J, Looney MR, López JA, Maas C, Peyvandi F, Ruf W, Sood AK, Versteeg HH, Wolberg AS, Wong PC, Wood JP, Weiler H.
Advances in Clinical and Basic Science of Coagulation: Illustrated abstracts of the 9th Chapel Hill Symposium on Hemostasis. 
Res Pract Thromb Haemost. 2018 Apr 12;2(3):407-428. 

Bianchini EP, Sebestyen A, Abache T, Bourti Y, Fontayne A, Richard V, Tamion F, Plantier JL, Doguet F, Borgel D.
Inactivated antithombin as anticoagulant reversal in a rat model of cardiopulmonary bypass: a potent and potentially safer alternative to protamine.
Br J Haematol. 2018 Mar;180(5):715-720.

Berrou E, Soukaseum C, Favier R, Adam F, Elaib Z, Kauskot A, Bordet JC, Ballerini P, Loyau S, Feng M, Dias K, Muheidli A, Girault S, Nurden AT, Turro E, Ouwehand WH, Denis CV, Jandrot-Perrus M, Rosa JP, Nurden P, Bryckaert M.
A mutation of the human EPHB2 gene leads to a major platelet functional defect. 
Blood. 2018 Nov 8;132(19):2067-2077.

Boccara O, Puzenat E, Proust S, Leblanc T, Lasne D, Hadj-Rabia S, Bodemer C.
The effects of sirolimus on Kasabach-Merritt phenomenon coagulopathy. 
Br J Dermatol. 2018, 178, e114-e116.

Brionne-François M, Bauters A, Mouton C, Voisin S, Flaujac C, Le Querrec A, Lasne D.
Guidelines for certification of International Normalized Ratio (INR) for vitamin K antagonists monitoring according to the EN ISO 22870 standards.
Ann Biol Clin (Paris). 2018, 76:271-299.

Calvez T, Chambost H, d’Oiron R, Dalibard V, Demiguel V, Doncarli A, Gruel Y, Huguenin Y, Lutz P, Rothschild C, Vinciguerra C, Goudemand J; for FranceCoag Collaborators.
Analyses of the FranceCoag cohort support differences in immunogenicity among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A.
Haematologica. 2018 Jan;103(1):179-189.

Casari C, Paul DS, Susen S, Lavenu-Bombled C, Harroche A, Piatt R, O Poe K, Lee RH, Bryckaert M, Christophe OD, Lenting PJ, Denis CV, Bergmeier W.
Protein kinase C signaling dysfunction in von Willebrand disease (p.V1316M)-type 2B platelets.
Blood Adv. 2018, 2, 1417-1428. 

Catieau B, Devos V, Chtourou S, Borgel D, Plantier JL.
Endothelial cell surface limits coagulation without modulating the antithrombin potency.
Thromb Res. 2018, 167:88-95.

Damamme A, Urien S, Borgel D, Lasne D, Krug P, Krid S, Charbit M, Salomon R, Treluyer JM, Boyer O.
Pharmacokinetics of Enoxaparin After Renal Transplantation in Pediatric Patients.
J Clin Pharmacol. 2018 Dec;58(12):1597-1603. 

Danger R, Royer PJ, Reboulleau D, Durand E, Loy J, Tissot A, Lacoste P, Roux A, Reynaud-Gaubert M, Gomez C, Kessler R, Mussot S, Dromer C, Brugière O, Mornex JF, Guillemain R, Dahan M, Knoop C, Botturi K, Foureau A, Pison C, Koutsokera A, Nicod LP, Brouard S, Magnan A; COLT and SysCLAD Consortia.
Blood Gene Expression Predicts Bronchiolitis Obliterans Syndrome.
Front Immunol. 2018;8:1841.

Denis CV, Lenting PJ.
VWF clearance : It’s glycomplicated.
Blood, 2018, 131, 842-843.

Farfour E, Lesprit P, Chan Hew Wai A, Mazaux L, Fourn E, Majerholc C, Bonan B, Vasse M, Zucman D.
Acute hepatitis A breakthrough in MSM in Paris area: implementation of targeted hepatitis A virus vaccine in a context of vaccine shortage.
AIDS. 2018;32(4):531-532. 

Farfour E, Trochu E, Devin C, Cardot Martin E, Limousin L, Roux A, Picard C, Jolly E, Vasse M, Lesprit P.
Trends in ceftazidime-avibactam activity against multidrug-resistant organisms recovered from respiratory samples of cystic fibrosis patients.
Transpl Infect Dis. 2018 Jun 13:e12955. 

Fiore M, d’Oiron R, Pillois X, and Alessi M-C. 
Anti-aIIbb3 immunization in Glanzmann thrombasthenia: review of literature and treatment recommendations. 
British J. Hematol. 2018, 181, 173-182.

Kauskot A, Pascreau T, Adam F, Bruneel A, Reperant C, Lourenco-Rodrigues MD, Rosa JP, Petermann R, Maurey H, Auditeau C, Lasne D, Denis CV, Bryckaert M, de Lonlay P, Lavenu-Bombled C, Melki J, Borgel D.
A mutation in the gene coding for the sialic acid transporter SLC35A1 is required for platelet life span but not proplatelet formation. 
Haematologica. 2018 Dec;103(12):e613-e617

Kossorotoff M, De Montalembert M, Brousse V, Lasne D, Curis E, Smadja DM, Lacroix R, Bertil S, Masson E, Desguerre I, Bonnet D, Gaussem P.
CD34+ Hematopoietic Stem Cell Count Is Predictive of Vascular Event Occurrence in Children with Sickle Cell Disease.
Stem Cell Rev. 2018, 14, 694-701. 

Kurdi M, Frère C, Amour J, Brumpt C, Delort J, Lebreton G, Croisille L, d’Oiron R, Martin-Toutain I.
Perioperative management of a patient with Glanzmann thrombasthenia undergoing a coronary artery bypass graft surgery: a case report.
Blood Coagul Fibrinolysis. 2018, 29, 327-329.

Laurent PA, Hechler B, Solinhac R, Ragab A, Cabou C, Anquetil T, Severin S, Denis CV, Mangin PH, Vanhaesebroeck B, Payrastre B, Gratacap MP.
Impact of PI3Kα (Phosphoinositide 3-Kinase Alpha) Inhibition on Hemostasis and Thrombosis. 
Arterioscler Thromb Vasc Biol. 2018 Sep;38(9):2041-2053.

Lamaa D, Lin HP, Zig L, Bauvais C, Bollot G, Bignon J, Levaique H, Pamlard O, Dubois J, Ouaissi M, Souce M, Kasselouri A, Saller F, Borgel D, Jayat-Vignoles C, Al-Mouhammad H, Feuillard J, Benihoud K, Alami M, Hamze A.
Design and Synthesis of Tubulin and Histone Deacetylase Inhibitor Based on iso-Combretastatin A-4. 
J Med Chem. 2018, 61, 6574-6591.

Lecuyer H, Virion, Z, Barnier JP, Matczak S, Bourdoulous S, Bianchini E, Saller F, Borgel D, Nassif X, Coureuil M.
An ADAM-10 dependent EPCR shedding links meningococcal interaction with endothelial cells to purpura fulminans. 
PLOS Pathogens. 2018, 14, e1006981.

López J, Albarran L, Jardin I, Sanchez-Collado J, Redondo Liberal P, Bermejo N, Bobe R, Smani T, and Rosado J.
Filamin A modulates store-operated Ca2+ entry by regulating STIM1-Orai1 association in human platelets.
Arterioscler Thromb Vasc Biol. 2018 Feb;38(2):386-397.

Meliani A, Boisgerault F, Hardet R, Marmier S, Collaud F, Ronzitti G, Leborgne C, Costa Verdera H, Simon Sola M, Charles S, Vignaud A, van Wittenberghe L, Manni G, Christophe O, Fallarino F, Roy C, Michaud A, Ilyinskii P, Kishimoto TK, Mingozzi F.
Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration.
Nat Commun. 2018 Oct 5;9(1):4098.

Muczynski V, Casari C, Moreau F, Aymé G, Kawecki C, Legendre P, Proulle V, Christophe OD, Denis CV, Lenting PJ.
A factor VIII-nanobody fusion protein forming an ultra-stable complex with VWF: effect on clearance & antibody formation.
Blood. 2018 Sep 13;132(11):1193-119

Naret T, Bignon J, Bernadat G, Benchekroun M, Levaique H, Lenoir C, Dubois J, Pruvost A, Saller F, Borgel D, Manoury B, Leblais V, Darrigrand R, Apcher S, Brion JD, Schmitt E, Leroux FR, Alami M, Hamze A.
A fluorine scan of a tubulin polymerization inhibitor isocombretastatin A-4: Design, synthesis, molecular modelling, and biological evaluation.
Eur J Med Chem. 2018 Jan 1;143:473-490.

Net P, Karnycheff F, Vasse M, Bourdain F, Bonan B, Lapergue B.
Urinary tract infection after acute stroke: Impact of indwelling urinary catheterization and assessment of catheter-use practices in French stroke centers.
Rev Neurol (Paris). 2018, 174, 145-149.

Prince R, Bologna L, Manetti M, Melchiorre D, Rosa I, Dewarrat N, Suardi S, Amini P, Fernandez JA, Burnier L, Quarroz C, Reina Caro MD, Matsumara Y, Kremer Hovinga JA, Griffin JH, Simon HU, Ibba-Manneschi L, Saller F, Calzavarini S, Angelillo-Scherrer A.
Targeting anticoagulant protein S to improve hemostasis in hemophilia. 
Blood 2018;131:1360-1371.

Rayes J, Jadoui S, Lax S, Gros A, Wichaiyo S, Ollivier V, Denis CV, Ware J, Nieswandt B, Jeandrot-Perrus M, Watson SP, Ho-Tin-Noé B.
The contribution of platelet glycoprotein receptors to inflammatory bleeding prevention is stimulus and organ dependent. 
Haematologica, 2018, 103, e256-e258. 

Stoupa A, Adam F, Kariyawasam D, Strassel C, Gawade S, Szinnai G, Kauskot A, Lasne D, Janke C, Natarajan K, Schmitt A, Bole-Feysot C, Nitschke P, Léger J, Jabot-Hanin F, Tores F, Michel A, Munnich A, Besmond C, Scharfmann R, Lanza F, Borgel D, Polak M, Carré A.
TUBB1 mutations cause thyroid dysgenesis associated with abnormal platelet physiology. 
EMBO Mol Med. 2018 Nov 16.

Vincent F, Rauch A, Loobuyck V, Robin E, Nix C, Vincentelli A, Smadja DM, Leprince P, Amour J, Lemesle G, Spillemaeker H, Debry N, Latremouille C, Jansen P, Capel A, Moussa M, Rousse N, Schurtz G, Delhaye C, Paris C, Jeanpierre E, Dupont A, Corseaux D, Rosa M, Sottejeau Y, Barth S, Mourran C, Gomane V, Coisne A, Richardson M, Caron C, Preda C, Ung A, Carpentier A, Hubert T, Denis C, Staels B, Lenting PJ, Van Belle E, Susen S.
Arterial pulsatility as a modulator of circulating Von Willebrand Factor in mechanical circulatory support devices.
J Am Coll Cardiol, 2018, 71, 2106-2118.

Vincent F, Rauch A, Loobuyck V, Moussa M, Debry N, Jeanpierre E, Juthier F, Lenting PJ, Susen S, van Belle E.
Von Willebrand Factor for Aortic Valve Intervention: from Bench to Real-time Bedside Assessment.
Circulation Res. 2018, 122, 1499-1500.

Wohner N, Muczynski V, Mohamadi A, Aymé G, Christophe OD, Lenting PJ, Denis CV, Casari C.
Macrophage scavenger-receptor SR-AI contributes to the clearance of von Willebrand factor.
Haematologica. 2018 Apr;103(4):728-737.

Aymé G, Adam F, Legendre P, Bazaa A, Proulle V, Denis CV, Christophe OD, Lenting PJ.
A novel single-domain antibody againts von Willebrand factor A1-domain resolves leukocyte recruitment and vascular leakage during inflammation. 
Arterioscler Thromb Vasc Biol. 2017, 37, 1736-1740.

Berrou E, Adam F, Lebret M, Planche V, Fergelot P, Issertial O, Coupry I, Bordet JC, Nurden P, Bonneau D, Colin E, Goizet C, Rosa JP, Bryckaert M.
Gain-of-Function Mutation in Filamin A Potentiates Platelet Integrin αIIbβ3 Activation. 
Arterioscler Thromb Vasc Biol. 2017, 37, 1087-1097

Bourti Y, Saller F, Bianchini EP, Pautus S, Duong van Huyen JP, Marie AL, Tran NT, Molina TJ, Taverna M, Lerolle N, Borgel D.
Antithrombin is not protective against renal ischaemia-reperfusion injury.
Thromb Haemost. 2017, 117, 422-425.

Caron C, Meley R, Le Cam Duchez V, Aillaud MF, Lavenu-Bombled C, Dutrillaux F, Flaujac C, Ryman A, Ternisien C, Lasne D, Galinat H, Pouplard C. Agreement between factor XIII activity and antigen assays in measurement of factor XIII: A French multicenter study of 147 human plasma samples. Int J Lab Hematol. 2017, 39, 279-285.

Casini A, Brungs T, Lavenu-Bombled C, Vilar R, Neerman-Arbez M, de Moerloose P. Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation. J Thromb Haemost. 2017, 15, 876-888.

Farfour E, Dimi S, Majerholc C, Fourn E, Séné T, Chaida MB, Vasse M, Zucman D. Increase in sexually transmitted infections in a cohort of outpatient HIV-positive men who have sex with men in the Parisian region. Med Mal Infect. 2017, 47(7):490-493.

Godier A, Dincq AS, Martin AC, Radu A, Leblanc I, Antona M, Vasse M, Golmard JL, Mullier F, Gouin-Thibault I. Predictors of pre-procedural concentrations of direct oral anticoagulants: a prospective multicentre study. Eur Heart J. 2017 Aug 14;38(31):2431-2439

Gwinner F, Boulday G, Vandiedonck C, Arnould M, Cardoso C, Nikolayeva I, Guitart-Pla O, Denis CV, Christophe OD, Beghain J, Tournier-Lasserve E, Schwikowski B. Network-based analysis of omics data: The LEAN method. Bioinformatics. 2017, 33, 701-709.

Helms J, Clere-Jehl R, Bianchini E, Le Borgne P, Burban M, Zobairi, F, Diehl JL, Grunebaum L, Toti T, Meziani F and Borgel D. Thrombomodulin favors leukocyte microvesicle fibrinolytic activity, reduces NETosis and prevents septic shock-induced coagulopathy in rats. Annals of intensive Care. 2017, Dec 8;7(1):118.

Kawecki C, Lenting PJ, Denis CV. Von Willebrand factor and inflammation. J Thromb Haemost. 2017, 15, 1285-1294.

Kirschbaum M, Jenne CN, Veldhuis ZJ, Sjollema KA, Lenting PJ, Giepmans BN, Porte RJ, Kubes P, Denis CV, Lisman T. Transient von Willebrand factor-mediated platelet influx stimulates liver regeneration after partial hepatectomy in mice. Liver International, 2017, 37, 1731-1737.

Lécuyer H, Borgel D, Nassif X, Coureuil M. Pathogenesis of meningococcal purpura fulminans. Pathog Dis. 2017 Apr 1;75(3).

Lenting PJ, Denis CV, Christophe OD. Emicizumab, a bispecific antibody recognizing coagulation factors IX and X: how does it actually compare to factor VIII? Blood, 2017, 130, 2463-2468.

Martinez de Lizarrondo S, Gakuba C, Herbig B, Repessé Y, Ali C, Denis CV, Lenting PJ, Touzé E, Diamond SL, Vivien D, Gauberti M. Potent thrombolytic effect of N-Acetylcysteine on arterial thrombi. Circulation, 2017, 136, 646-660.

Meliani A, Boisgerault F, Fitzpatrick Z, Marmier S, Leborgne C, Collaud F, Simon Sola M, Charles S, Ronzitti G, Vignaud A, van Wittenberghe L, Marolleau B, Jouen F, Tan S, Boyer O, Christophe O, Brisson AR, Maguire CA, Mongozzi F. Enhanced liver gene transfer and evasion of preexisting humoral immunity with exosome-enveloped AAV vectors. Blood Adv 2017; 1:2019-2031 doi:10.1182.

Muczinsky V, Aymé G, Regnault V, Vasse M, Borgel D, Legendre P, Bazaa A, Harel A, Loubière C, Lenting PJ, Denis CV, Christophe OD. et al. Complex formation with Pentraxin-2 regulates Factor X plasma levels and macrophage interactions. Blood, 2017, 129, 2443-2454.

Muczynski V, Christophe OD, Denis CV, Lenting PJ. Emerging Therapeutic Strategies in the Treatment of Hemophilia A. Semin Thromb Hemost. 2017, 43, 581-590.

Petit M, Mine L, Pascreau T, Brouzes C, Majoux S, Borgel D, Beaudeux JL, Lasne D, Hennequin C. Preanalytical influence of pneumatic tube delivery system on results of routine biochemistry and haematology analysis. Ann Biol Clin (Paris). 2017 Oct 18.

Rapetti-Mauss R, Picard V, Guitton C, Ghazal K, Proulle V, Badens C, Soriani O, Garçon L, Guizouarn H. Red blood cell Gardos channel (KCNN4):the essential determinant of erythrocyte dehydration in Hereditary Xerocytosis. Haematologica. 2017, 102, e415-e418.

Rodero MP, Tesser A, Bartok E, Rice GI, Della Mina E, Depp M, Beitz B, Bondet V, Cagnard N, Duffy D, Dussiot M, Frémond ML, Gattorno M, Guillem F, Kitabayashi N, Porcheray F, Rieux-Laucat F, Seabra L, Uggenti C, Volpi S, Zeef LAH, Alyanakian MA, Beltrand J, Bianco AM, Boddaert N, Brouzes C, Candon S, Caorsi R, Charbit M, Fabre M, Faletra F, Girard M, Harroche A, Hartmann E, Lasne D, Marcuzzi A, Neven B, Nitschke P, Pascreau T, Pastore S, Picard C, Picco P, Piscianz E, Polak M, Quartier P, Rabant M, Stocco G, Taddio A, Uettwiller F, Valencic E, Vozzi D, Hartmann G, Barchet W, Hermine O, Bader-Meunier B, Tommasini A, Crow YJ. Type I interferon-mediated autoinflammation due to DNase II deficiency. Nat Commun. 2017 Dec 19;8(1):2176.

Schiff M, Roda C, Monin ML, Arion A, Barth M, Bednarek N, Bidet M, Bloch C, Boddaert N, Borgel D, Brassier A, Brice A, Bruneel A, Buissonnière R, Chabrol B, Chevalier MC, Cormier-Daire V, De Barace C, De Maistre E, De Saint-Martin A, Dorison N, Drouin-Garraud V, Dupré T, Echenne B, Edery P, Feillet F, Fontan I, Francannet C, Labarthe F, Gitiaux C, Héron D, Hully M, Lamoureux S, Martin-Coignard D, Mignot C, Morin G, Pascreau T, Pincemaille O, Polak M, Roubertie A, Thauvin-Robinet C, Toutain A, Viot G, Vuillaumier-Barrot S, Seta N, De Lonlay P. Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation) and review of the literature. J Med Genet. 2017 Dec;54(12):843-851.

Seck M, Costa C, Faye BF, Sy Bah D, Touré SA, Dieng N, Sall A, Gadji M, Touré AO, Lasne D, Rothschild C, Diop S. Molecular diagnosis of haemophilia A in patients from Senegal. Haemophilia. 2017 May;23(3):e225-e227.

Seck M, Faye BF, Sall A, Sy D, Touré SA, Dieng N, Guéye YB, Gadji M, Touré AO, Costa C, Lasne D, Rothschild C, Diop S. Bleeding risk assessment in hemophilia A carriers from Dakar, Senegal. Blood Coagul Fibrinolysis. 2017, 28(8):642-645.

Trochu E, Cardot E, Cahen P, Mathonnet D, Donato N, Vasse M, Farfour E. Validation of the identification of Streptococcus pneumoniae and oral streptococci by MALDI-TOF Microflex-LT. Ann Biol Clin (Paris). 2017, 75, 356-358.

Zucman D, Farfour E, Mazaux L, Hillaire S, Dimi S, Lesprit P, Khan JE, Vasse M. How to face the outbreak of viral hepatitis A in men-who-have-sex-with-men in France without vaccines? Clin Infect Dis. 2017, 65(6):1053-1054.

Abdelmagid N, Bereczky-Veress B, Atanur S, Musilová A, Zídek V, Saba L, Warnecke A, Khademi M, Studahl M, Aurelius E, Hjalmarsson A, Garcia-Diaz A, Denis CV, Bergström T, Sköldenberg B, Kockum I, Aitman T, Hübner N, Olsson T, Pravenec M, Diez M. Von Willebrand factor gene variants associate with Herpes simplex encephalitis. PLoS One. 2016 May 25;11(5):e0155832.

Adam F, Casari C, Prévost N, Kauskot A, Loubière C, Legendre P, Repérant C, Baruch D, Rosa JP, Bryckaert M, de Groot PG, Christophe OD, Lenting PJ, Denis CV. A genetically-engineered von Willebrand disease type 2B mouse model displays defects in hemostasis and inflammation. Sci Rep. 2016 May 23;6:26306.

Adam F, Khatib AM, Javier Lopez J, Vatier C, Turpin S, Muscat A, Soulet F, Aries A, Jardin I, Bobe R, Stepanian A, De Prost D, Dray C, Rosado J, Valet P, Feve B, Siegfried G. Apelin: an antithrombotic factor that inhibits platelet function.
Blood. 2016 Feb 18;127(7):908-20.

Bourti Y, Fazavana J, Armand M, Saller F, Lasne D, Borgel D, Bianchini EP. Inactivated antithrombins as fondaparinux antidotes: a promising alternative to haemostatic agents as assessed in vitro in a thrombin-generation assay. Thromb Haemost. 2016, 116, 452-460.

Cortier D, Van Dreden P, Adam M, Bironien R, François D, Vasse M. Transient Factor V deficiency associated with Factor V-immunoglobulin complexes but without evidence of a classical inhibitor. Thromb Res. 2016, 147, 10-12.

Elaïb Z, Adam F, Berrou E, Bordet JC, Prévost N, Bobe R, Bryckaert M, Rosa JP. Full activation of mouse platelets requires an ADP secretion pathway regulated by SERCA3 ATPase-dependent calcium stores. Blood. 2016, 128, 1129-1138.

Elaib Z, Saller F, Bobe R. The Calcium Entry-Calcium Refilling Coupling. Adv Exp Med Biol. 2016, 898, 333-352.

El Golli N, Dkhili H, Dallagi Y, Rahali D, Lasram M, Bini-Dhouib I, Lebret M, Rosa JP, El Fazaa S, Asmi MA. Comparison between electronic cigarette refill liquid and nicotine on metabolic parameters in rats. Life Sci. 2016, 146:131-8

El Golli N, Rahali D, Jrad-Lamine A, Dallagi Y, Jallouli M, Bdiri Y, Ba N, Lebret M, Rosa JP, El May M, El Fazaa S. Impact of electronic-cigarette refill liquid on rat testis. Toxicol Mech Methods. 2016 Jul;26(6):427-34

Espitia O, Ternisien C, Agard C, Boisseau P, Denis CV, Fouassier M. Use of a thrombopoietin receptor agonist in von Willebrand disease type 2B (p.V1316M) with severe thrombocytopenia and intracranial hemorrhage. Platelets. 2016 Nov 25:1-3

Fazavana JG, Muczynski V, Proulle V, Wohner N, Christophe OD, Lenting PJ, Denis CV. LRP1 contributes to the clearance of the Factor VIIa/antithrombin complex. J Thromb Haemost. 2016, 14, 2458-2470.

Kauskot A, Poirault-Chassac S, Adam F, Muczynski V, Aymé G, Casari C, Bordet JC, Soukaseum C, Rothschild C, Proulle V, Pietrzyk-Nivau A, Berrou E, Christophe OD, Rosa JP, Lenting PJ, Bryckaert M, Denis CV, Baruch D. LIM kinase/cofilin dysregulation promotes macrothrombocytopenia in severe von Willebrand disease-type 2B. JCI Insight. 2016 Oct 6;1(16):e88643.

Khatib AM, Lahlil R, Hagedorn M, Delomenie C, Christophe O, Denis C, Siegfried G. Biological outcome and mapping of total factor cascades in response to HIF induction during regenerative angiogenesis. Oncotarget, 2016, 7, 12102-12120. 

Lavenu-Bombled C, Guitton C, Dupuis A, Baas MJ, Desconclois C, Dreyfus M, Li R, Caron C, Gachet C, Fressinaud E, Lanza F. A novel platelet-type von Willebrand disease mutation (GP1BA p.Met255Ile) associated with type 2B « Malmö/New York » von Willebrand disease. Thromb Haemost. 2016, 116, 1070-1078.

Le Besnerais M, Favre J, Denis CV, Mulder P, Martinet J, Nicol L, Levesque H, Veyradier A, Kopić A, G Motto D, Coppo P, Richard V, Benhamou Y. Assessment of endothelial damage and cardiac injury in a mouse model mimicking thrombotic thrombocytopenic purpura. J Thromb Haemost. 2016, 14, 1917-1930. 

Lenting PJ, Denis CV, Susen S, van Belle E. Antibody-Based Protection of von Willebrand Factor Degradation. JACC Heart Fail. 2016 Jun;4(6):518.

Marie AL, Tran NT, Saller F, Abdou YM, Zeau P, Plantier JL, Urbain R, Borgel D, Taverna M. A capillary zone electrophoresis method to detect conformers and dimers of antithrombin in therapeutic preparations. Electrophoresis. 2016 Jul;37(12):1696-703

Marie AL, Dominguez-Vega E, Saller F, Plantier JL, Urbain R, Borgel D, Tran NT, Somsen GW, Taverna M. Characterization of conformers and dimers of antithrombin by capillary electrophoresis-quadrupole-time-of-flight mass spectrometry. Anal Chim Acta. 2016, 947, 958-965.

Mathieu E, Van Dreden P, Aulagnier J, Grusse M, Dreyfus JF, François D, Vasse M. Decreased levels of procoagulant phospholipids in bleeding patients treated by vitamin K antagonists. Thromb Res. 2016, 137:36-40.

Montalvan B, Le Goux P, Klouche S, Borgel D, Hardy P, Breban M. Inefficacy of ultrasound-guided local injections of autologous conditioned plasma for recent epicondylitis: results of a double-blind placebo-controlled randomized clinical trial with one-year follow-up. Rheumatology (Oxford). 2016, 55, 279-285.

Muczynski V, Bazaa A, Loubière C, Harel A, Cherel G, Denis CV, Lenting PJ, Christophe OD. Macrophage receptor SR-AI is crucial to maintain normal plasma levels of coagulation factor X. Blood. 2016 Feb 11;127(6):778-86

Obser T, Ledford-Kraemer M, Oyen F, Brehm MA, Denis CV, Marschalek R, Montgomery RR, Sadler JE, Schneppenheim S, Budde U, Schneppenheim R. Identification and characterization of the elusive mutation causing the historical von Willebrand Disease type IIC Miami. J Thromb Haemost. 2016, 14, 1725-1735.

Pautus S, Alami M, Adam F, Bernadat G, Lawrence DA, De Carvalho A, Ferry G, Rupin A, Hamze A, Champy P, Bonneau N, Gloanec P, Peglion JL, Brion JD, Bianchini EP, Borgel D. Characterization of the Annonaceous acetogenin, annonacinone, a natural product inhibitor of plasminogen activator inhibitor-1. Sci Rep. 2016 Nov 23;6:36462.

Pepin M, Mezouar S, Pegon J, Muczynski V, Adam F, Bianchini EP, Bazaa A, Proulle V, Rupin A, Paysant J, Panicot-Dubois L, Christophe OD, Dubois C, Lenting PJ, Denis CV. Soluble Siglec-5 associates to PSGL-1 and displays anti-inflammatory activity. Sci Rep. 2016 Nov 28;6:37953.

Pipe SW, Montgomery RR, Pratt KP, Lenting PJ, Lillicrap D. Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A. Blood, 2016, 128, 2007-2016.

Rauch A, Caron C, Vincent F, Jeanpierre E, Ternisien C, Boisseau P, Zawadzki C, Fressinaud E, Borel-Derlon A, Hermoire S, Paris C, Lavenu-Bombled C, Veyradier A, Ung A, Vincentelli A, van Belle E, Lenting PJ, Goudemand J, Susen S. A novel ELISA-based diagnosis of acquired VWD with increased VWF proteolysis. Thromb Haemost. 2016, 115, 950-959.

Rossi E, Smadja DM, Boscolo E, Langa C, Arevalo MA, Pericacho M, Gamella-Pozuelo L, Kauskot A, Botella LM, Gaussem P, Bischoff J, Lopez-Novoa JM, Bernabeu C. Endoglin regulates mural cell adhesion in the circulatory system.
Cell Mol Life Sci. 2016, 73, 1715-1739.

Van Belle E, Rauch A, Vincent F, Robin E, Kibler M, Labreuche J, Jeanpierre E, Levade M, Hurt C, Rousse N, Dally JB, Debry N, Dallongeville J, Vincentelli A, Delhaye C, Auffray JL, Juthier F, Schurtz G, Lemesle G, Caspar T, Morel O, Dumonteil N, Duhamel A, Paris C, Dupont-Prado A, Legendre P, Mouquet F, Marchant B, Hermoire S, Corseaux D, Moussa K, Manchuelle A, Bauchart JJ, Loobuyck V, Caron C, Zawadzki C, Leroy F, Bodart JC, Staels B, Goudemand J, Lenting PJ, Susen S. Von Willebrand Factor Multimers during Transcatheter Aortic-Valve Replacement. N Engl J Med. 2016 Jul 28;375(4):335-44.

Veyradier A, Boisseau P, Fressinaud E, Caron C, Ternisien C, Giraud M, Zawadzki C, Trossaert M, Itzhar-Baïkian N, Dreyfus M, d’Oiron R, Borel-Derlon A, Susen S, Bezieau S, Denis CV, Goudemand J; French Reference Center for von Willebrand disease. A Laboratory Phenotype/Genotype Correlation of 1167 French Patients From 670 Families With von Willebrand Disease: A New Epidemiologic Picture. Medicine (Baltimore). 2016 Mar;95(11):e3038.

Unité 1176

Berrou E, Kauskot A, Adam F, Harel A, Legendre P, Lavenu Bombled C, Rothschild C, Prevost N, Christophe OD, Lenting PJ, Denis CV, Rosa JP, Bryckaert M. Apoptotic Platelet Events Are Not Observed in Severe von Willebrand Disease-Type 2B Mutation p.V1316M.
PLoS One. 2015 Dec 8;10(12):e0143896.

Bryckaert M, Rosa JP, Denis CV, Lenting PJ. Of von Willebrand factor and platelets.
Cell Mol Life Sci. 2015, 72, 307-326.

Decouture B, Dreano E, Belleville-Rolland T, Kuci O, Dizier B, Bazaa A, Coqueran B, Lompre AM, Denis CV, Hulot JS, Bachelot-Loza C, Gaussem P. Impaired platelet activation and cAMP homeostasis in MRP4-deficient mice.
Blood. 2015 Oct 8;126(15):1823-30.

Lenting PJ, Christophe OD, Denis CV. Von Willebrand factor biosynthesis, secretion & clearance : connecting the far ends.
Blood. 2015 Mar 26;125(13):2019-2028

Lhote R, Theodore C, Issoufaly T, Francois D, Kahn JE, Guillevin L, Rivaud E, Bron C, Vasse M, Couderc LJ, Tcherakian C. Successful treatment of antineutrophil cytoplasmic antibody-associated bronchiectasis with immunosuppressive therapy.
Eur Respir J. 2015 Aug;46(2):554-7.

Marie AL, Tran NT, Bianchini EP, Saller F, Pautus S, Abache T, Plantier JL, Urbain R, Borgel D, Taverna M. A fast capillary electrophoresis method to assess the binding affinity of recombinant antithrombin toward heparin directly from cell culture supernatants.
J Pharm Biomed Anal. 2015 Jul 10;111:64-70.

Net P, Karnycheff F, Butreau M, Lesprit P, Szekely B, Vasse M, Neuzillet Y, Lebret T, Bonan B. Controverse sur l’antibioprophylaxie lors des néphrectomies. Prog Urol. 2015 Nov;25(13):776-7.

Perrin J, Charron C, François JH, Cramer-Bordé E, Lévy B, Borgel D, Vieillard-Baron A. Coagulation phenotypes in septic shock as evaluated by calibrated automated thrombography.
Shock. 2015 Jan;43(1):74-9.

Pietrzyk-Nivau A, Poirault-Chassac S, Gandrille S, Derkaoui SM, Kauskot A, Letourneur D, Le Visage C, Baruch D. Three-Dimensional Environment Sustains Hematopoietic Stem Cell Differentiation into Platelet-Producing Megakaryocytes.
PLoS One. 2015 Aug 27;10(8):e0136652.

Ralay-Ranaivo B, Borgel D, Couvreur P, Gref R. Trends in the development of oral anticoagulants.
Ther Deliv. 2015 Jul;6(6):685-703. 

Ramos-Kuri M, Rapti K, Mehel H, Zhang S, Dhandapany PS, Liang L, García-Carrancá A, Bobe R, Fischmeister R, Adnot S, Lebeche D, Hajjar RJ, Lipskaia L, Chemaly ER. Dominant negative Ras attenuates pathological ventricular remodeling in pressure overload cardiac hypertrophy.
Biochim Biophys Acta. 2015 Nov;1853(11 Pt A):2870-84. 

Strassel C, Kubovcakova L, Mangin PH, Ravanat C, Freund M, Skoda RC, Denis CV, Dupuis A, Herbrecht E, Gachet C, Lanza F. Hemorrhagic and thrombotic diatheses in mouse models with thrombocytosis.
Thromb Haemost. 2015,113, 414-425.

Sun Y, Vandenbriele C, Kauskot A, Verhamme P, Hoylaerts MF, Wright GJ. A human platelet receptor protein microarray identifies FcεR1α as an activating PEAR1 ligand.
Mol Cell Proteomics. 2015 May;14(5):1265-74.

Susen S, Rauch A, Van Belle E, Vincentelli A, Lenting PJ. Circulatory support devices: fundamental aspects and clinical management of bleeding and thrombosis.
J Thromb Haemost. 2015 Oct;13(10):1757-67.

Van Belle E, Rauch A, Vincentelli A, Jeanpierre E, Legendre P, Juthier F, Hurt C, Banfi C, Rousse N, Godier A, Caron C, Elkalioubie A, Corseaux D, Dupont A, Zawadzki C, Delhaye C, Mouquet F, Schurtz G, Deplanque D, Chinetti-Gbaguidi G, Staels B, Goudemand JY, Jude B, Lenting P, Susen S. von Willebrand Factor as a Biological Sensor of Blood Flow to Monitor Percutaneous Aortic Valve Interventions.
Circ Res. 2015 Mar 27;116(7):1193-201

Vandenbriele C, Kauskot A, Vandersmissen I, Criel M, Geenens R, Craps S, Luttun A, Janssens S, Hoylaerts MF, Verhamme P. Platelet endothelial aggregation receptor-1: a novel modifier of neoangiogenesis.
Cardiovasc Res. 2015 Oct 1;108(1):124-38.

Vasse M, Colin S, Guilmain W, Creoff E, Muraine M, Vannier JP, Al-Mahmood S. [Tetraspanins: a new target for antiangiogenic therapy?].
Ann Pharm Fr. 2015 Mar;73(2):100-7.

Wohner N, Legendre P, Casari C, Christophe OD, Lenting PJ, Denis CV. Shear stress-independent binding of von Willebrand factor-type 2B mutants p.R1306Q & p.V1316M to LRP1 explains their increased clearance.
J Thromb Haemost. 2015 May;13(5):815-20

Unité 770 et EA4531

Amsellem V, Lipskaia L, Abid S, Poupel L, Houssaini A, Quarck R, Marcos E, Mouraret N, Parpaleix A, Bobe R, Gary-Bobo G, Saker M, Dubois-Randé JL, Gladwin MT, Norris KA, Delcroix M, Combadière C, Adnot S. CCR5 as a Treatment Target in Pulmonary Arterial Hypertension.
Circulation. 2014, 130, 880-891.

Berthelot E, Lavenu-Bombled C, Orostegui-Giron L, Desconclois C, Assayag P. Impaired renal function and bleeding in elderly treated with dabigatran.
Blood Coagul Fibrinolysis. 2014, 25, 618-620.

Blirando K, Lipskaia L, Keuylian Z, Rouxel C, Blaise R, Adnot S, Hajjar R, Chemaly E, Limon I,Bobe R. P374Expression pattern of sarco (endo) plasmic reticulum calcium atpases (SERCA) isoforms in normal and diseased mouse cardiovascular tissues. Cardiovasc Res. 2014, 103 Suppl 1 : S368.

Chuah MK, Petrus I, De Bleser P, Le Guiner C, Gernoux G, Adjali O, Nair N, Willems J, Evens H, Rincon MY, Matrai J, Di Matteo M, Samara-Kuko E, Yan B, Acosta-Sanchez A, Meliani A, Cherel G, Blouin V, Christophe O, Moullier P, Mingozzi F, Driessche TV. Liver-Specific Transcriptional Modules Identified by Genome-Wide in Silico Analysis Enable Efficient Gene Therapy in Mice and Non-Human Primates.
Mol Ther. 2014, 22, 1605-1613.

Desconclois C, Eschwège V, Proulle V, Boutekedjiret T, Dreyfus M, Toulon P. Underestimation of unfractionated heparin therapy assessment due to platelet activation when using partial-draw (pediatric) citrate collection tubes.
Thromb Res. 2014, 134, 1117-1122.

Doat S, Borgel D, François JH, Bianchini E, Botton J, François D, Mitry E, Vasse M. Unbalance between plasma levels of Protein Z and protein Z-dependent inhibitor in patients with colorectal and pancreatic cancer: a pilot study.
Thromb Res. 2014 Feb;133(2):299-300. 

Fall AO, Proulle V, Sall A, Mbaye A, Ba PS, Diao M, Seck M, Gadji M, Gning SB, Diop S, Dièye TN, Faye BF, Thiam D, Dreyfus M. Risk factors for thrombosis in an african population.
Clin Med Insights Blood Disord. 2014, 7, 1-6.

Hervé D, Philippi A, Belbouab R, Zerah M, Chabrier S, Collardeau-Frachon S, Bergametti F, Essongue A, Berrou E, Krivosic V, Sainte-Rose C, Houdart E, Adam F, Billiemaz K, Lebret M, Roman S, Passemard S, Boulday G, Delaforge A, Guey S, Dray X, Chabriat H, Brouckaert P,Bryckaert M, Tournier-Lasserve E. Loss of α1β1 Soluble Guanylate Cyclase, the Major Nitric Oxide Receptor, Leads to Moyamoya and Achalasia.
Am J Hum Genet. 2014, 94, 385-394.

Hie M, Gay J, Galicier L, Provôt F, Presne C, Poullin P, Bonmarchand G, Wynckel A, Benhamou Y, Vanhille P, Servais A, Bordessoule D, Coindre JP, Hamidou M, Vernant JP, Veyradier A, Coppo P; French Thrombotic Microangiopathies Reference Centre. Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura.
Blood. 2014, 124, 204-210.

Hillgruber C, Kathrin Steingräber A, Pöppelmann B, Denis CV, Ware J, Vestweber D, Nieswandt B, Schneider SW, Goerge T. Blocking Von Willebrand Factor for Treatment of Cutaneous Inflammation.
J Invest Dermatol. 2014, 134, 77-86.

Joly B, Stepanian A, Hajage D, Thouzeau S, Capdenat S, Coppo P, Veyradier A. Evaluation of a chromogenic commercial assay using VWF-73 peptide for ADAMTS13 activity measurement.
Thromb Res. 2014, 134, 1074-1080.

Kawecki C, Hézard N, Bocquet O, Poitevin G, Rabenoelina F, Kauskot A, Duca L, Blaise S, Romier B, Martiny L, Nguyen P, Debelle L, Maurice P. Elastin-derived peptides are new regulators of thrombosis.
Arterioscler Thromb Vasc Biol. 2014 Dec;34(12):2570-8.

Lamrani L, Lacout C, Ollivier V, Denis CV, Gardiner A, Ho Tin Noe B, Vainchenker W, Villeval JL, Jandrot-Perrus M. Hemostatic disorders in a JAK2V617F-driven mouse model of myeloproliferative neoplasm.
Blood. 2014, 124, 1136-1145.

Le Behot A, Gauberti M, Martinez de Lizarrondo S, Montagne A, Lemarchand E, Repesse Y, Guillou S, Denis CV, Maubert E, Orset C, Vivien D. GpIbα-VWF blockade restores vessel patency by dissolving platelet aggregates formed under very high shear rate in mice.
Blood. 2014, 123, 3354-3363.

Lipskaia L, Bobe R, Chen J, Turnbull IC, Lopez JJ, Merlet E, Jeong D, Karakikes I, Ross AS, Liang L, Mougenot N, Atassi F, Lompré AM, Tarzami ST, Kovacic JC, Kranias E, Hajjar RJ, Hadri L. Synergistic Role of Protein Phosphatase Inhibitor 1 and SERCA2a in the Acquisition of the Contractile Phenotype of Arterial Smooth Muscle Cells.
Circulation. 2014, 129, 773-785.

Lipskaia L, Keuylian Z, Blirando K, Mougenot N, Jacquet A, Rouxel C, Sghairi H, Elaib Z, Blaise R, Adnot S, Hajjar RJ, Chemaly ER, Limon I, Bobe R. Expression of sarco (endo) plasmic reticulum calcium ATPase (SERCA) system in normal mouse cardiovascular tissues, heart failure and atherosclerosis.
Biochim Biophys Acta. 2014, 1843, 2705-2718.

Manchev VT, Hilpert M, Berrou E, Elaib Z, Aouba A, Boukour S, Souquere S, Pierron G, Rameau P, Andrews R, Lanza F, Bobe R, Vainchenker W, Rosa JP, Bryckaert M, Debili N, Favier R, Raslova H. A new form of macrothrombocytopenia induced by a germline mutation in PRKACG gene.
Blood. 2014, 124, 2705-2718.

Morgand M, Buffet M, Busson M, Loiseau P, Malot S, Amokrane K, Fortier C, London J, Bonmarchand G, Wynckel A, Provôt F, Poullin P, Vanhille P, Presne C, Bordessoule D, Girault S, Delmas Y, Hamidou M, Mousson C, Vigneau C, Lautrette A, Pourrat J, Galicier L, Azoulay E, Pène F, Mira JP, Rondeau E, Ojeda-Uribe M, Charron D, Maury E, Guidet B, Veyradier A, Tamouza R, Coppo P; Thrombotic Microangiopathies Reference Center. High prevalence of infectious events in thrombotic thrombocytopenic purpura and genetic relationship with toll-like receptor 9 polymorphisms: experience of the French Thrombotic Microangiopathies Reference Center.
Transfusion. 2014, 54, 389-397.

Morioka Y, Casari C, Wohner N, Cho S, Kurata S, Kitano A, Christophe OD, Lenting PJ, Li R,Denis CV, Prévost N. Expression of a structurally constrained von Willebrand factor variant triggers acute thrombotic thrombocytopenic purpura in mice.
Blood. 2014, 123, 3344-3353.

Ralay-Ranaivo B, Desmaële D, Bianchini EP, Lepeltier E, Bourgaux C, Borgel D, Pouget T, Tranchant JF, Couvreur P, Gref R. Novel self assembling nanoparticles for the oral administration of fondaparinux: synthesis, characterization and in vivo evaluation.
J Control Release. 2014 Nov 28;194:323-31

Rauch A, Legendre P, Christophe OD, Goudemand J, Van Belle E, Vincentelli A, Denis CV, Susen S, Lenting PJ. Antibody-based prevention of von Willebrand factor degradation mediated by circulatory assist devices.
Thromb Haemost. 2014, 112, 1014-1023.

Rayes J, Roumenina LT, Dimitrov JD, Repessé Y, Ing M, Christophe O, Jokiranta TS, Halbwachs-Mecarelli L, Borel-Derlon A, Kaveri SV, Frémeaux-Bacchi V, Lacroix-Desmazes S. The interaction between factor H and VWF increases factor H cofactor activity and regulates VWF prothrombotic status.
Blood. 2014, 123, 121-125.

Savoia A, Kunishima S, De Rocco D, Zieger B, Rand ML, Pujol-Moix N, Caliskan U, Tokgoz H, Pecci A, Noris P, Srivastava A, Ward C, Morel-Kopp MC, Alessi MC, Bellucci S, Beurrier P, de Maistre E, Favier R, Hézard N, Hurtaud-Roux MF, Latger-Cannard V, Lavenu-Bombled C,Proulle V, Meunier S, Négrier C, Nurden A, Randrianaivo H, Fabris F, Platokouki H, Rosenberg N, HadjKacem B, Heller PG, Karimi M, Balduini CL, Pastore A, Lanza F. Spectrum of the Mutations in Bernard-Soulier Syndrome.
Hum Mutat. 2014, 35, 1033-1045.

Suo J, Linke B, Meyer Dos Santos S, Pierre S, Stegner D, Zhang DD, Denis CV, Geisslinger G, Nieswandt B, Scholich K. Neutrophils mediate edema formation but not mechanical allodynia during zymosan-induced inflammation.
J Leukoc Biol. 2014, 96, 133-142.

 Unité 770 et EA4531

Berrou E, Adam F, Lebret M, Fergelot P, Kauskot A, Coupry I, Jandrot-Perrus M, Nurden A, Favier R, Rosa JP, Goizet C, Nurden P, Bryckaert M. Heterogeneity of platelet functional alterations in patients with filamin a mutations.
Arterioscler Thromb Vasc Biol. 2013, 33, e11-8.

Borgi A, Khemiri M, Veyradier A, Kazdaghli K, Barsaoui S. Congenital Thrombotic Thrombocytopenic Purpura: Atypical Presentation and New ADAMTS 13 Mutation in a Tunisian Child.
Mediterr J Hematol Infect Dis. 2013 Jun 3;5(1):e2013041.

Casari C, Lenting PJ, Christophe OD, Denis CV. Von Willebrand Factor Abnormalities Studied in the Mouse Model: What We Learned about VWF Functions.
Mediterr J Hematol Infect Dis. 2013, 5(1), e2013047.

Casari C, Du V, Wu Y-P, Kauskot A, De Groot PG, Christophe OD, Denis CV, De Laat B, Lenting PJ. Accelerated uptake of VWF/platelet complexes in macrophages contribute to VWD-type 2B associated thrombocytopenia.
Blood. 2013, 122, 2893-2902.

Casari C*, Berrou E*, Lebret M, Adam F, Kauskot A, Bobe R, Desconclois C, Fressinaud E, Christophe OD, Lenting PJ, Rosa JP, Denis CV, Bryckaert M. Von Willebrand factor mutation promotes thrombocytopathy by inhibiting integrin aIIbb3.
J Clin Invest. 2013, 123, 5071-5081.

Casari C, Lenting PJ, Wohner N, Christophe OD, Denis CV. Clearance of von Willebrand factor.
J. Thromb. Haemost. 2013, 11 Suppl 1, 202-2011.

Fazavana J, Bianchini E, Saller F, Smadja C, Picard V, Taverna M, Borgel D. A chemically modified inactive antithrombin as a potent antagonist of fondaparinux and heparinsanticoagulant activity.
J Thromb Haemost. 2013;11:1128-1136.

Legendre P, Navarrete AM, Rayes J, Casari C, Boisseau P, Ternisien C, Caron C, Fressinaud E, Goudemand J, Veyradier A, Denis CV, Lenting PJ, Christophe OD. Mutations in the A3 domain of Von Willebrand factor inducing combined qualitative and quantitative defects in the protein.
Blood, 2013, 121, 2135-2143.

Lenting PJ, Denis CV, Wohner N. Von Willebrand factor and thrombosis: risk factor, mediator and pharmacological target.
Curr Vasc Pharmacol. 2013, 11, 448-456.

Lerolle N Carlotti A, Dumenil G, Melican K, Pierrot M, Diehl JL, Caille V, Hékimian G, Gandrille S, Mandet C, Bruneval P, Borgel D. Assessment of the interplay between blood and skin vascular abnormalities in adult purpura fulminans: a prospective multicenter study.
Am J Resp Crit Care. 2013;188:684-92.

Lipskaia L, Hadri L, Lopez JJ, Hajjar RJ, Bobe R. Benefit of SERCA2a Gene Transfer to Vascular Endothelial and Smooth Muscle Cells: A New Aspect in Therapy of Cardiovascular Diseases.
Curr Vasc Pharmacol. 2013, 11, 465-479.

Loirat C, Coppo P, Veyradier A. Thrombotic thrombocytopenic purpura in children.
Curr Opin Pediatr. 2013, 25, 216-224.

Lopez JJ, Palazzo A, Chaabane C, Albarran L, Polidano E, Lebozec K, Dally S, Nurden P, Enouf J, Debili N, Bobe R. Crucial role for endoplasmic reticulum stress during megakaryocyte maturation.
Arterioscler Thromb Vasc Biol. 2013, 33, 2750-2758.

Maione L, Albarel F, Bouchard P, Gallant M, Flanagan CA, Bobe R, Cohen-Tannoudji J, Pivonello R, Colao A, Brue T, Millar RB, Lombès M, Young J, Guiochon-Mantel A, Bouligand J. R31C GNRH1 mutation and congenital hypogonadotropic hypogonadism.
PLOS one. 2013,8(7):e69616.

Mariotte E, Blet A, Galicier L, Darmon M, Parquet N, Lengline E, Boutboul D, Canet E, Traineau R, Schlemmer B, Veyradier A, Azoulay E. Unresponsive thrombotic thrombocytopenic purpura in critically ill adults.
Int Care Med. 2013, 39, 1272-1281.

McIntosh J, Lenting PJ, Rosales C, Lee D, Rabbanian S, Raj D, Patel N, Tuddenham EG, Christophe OD, McVey JH, Waddington S, Nienhuis AW, Gray JT, Fagone P, Mingozzi F, Zhou SZ, High KA, Cancio M, Ng CY, Zhou J, Morton CL, Davidoff AM, Nathwani AC. Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant.
Blood, 2013, 121, 3335-3344.

Poirault-Chassac S, Nguyen KA, Pietrzyk A, Casari C, Veyradier A, Denis CV, Baruch D. Terminal platelet production is regulated by von Willebrand factor.
PLoS One. 2013, 8, e63810.

Rauch A, Wohner N, Christophe OD, Denis CV, Susen S, Lenting PJ. On the versatility of von Willebrand factor.
Mediterr J Hematol Infect Dis. 2013, 5(1), e2013046.

Schaff M, Tang C, Maurer E, Bourdon C, Receveur N, Eckly A, Hechler B, Arnold C, de Arcangelis A, Nieswandt B, Denis CV, Lefebvre O, Georges-Labouesse E, Gachet C, Lanza F, Mangin PH. Integrin α6β1 is the main receptor for vascular laminins and plays a role in platelet adhesion, activation and arterial thrombosis.
Circulation, 2013, 128, 541-552.

Stepanian A, Bourguignat L, Hennou S, Coupaye M, Hajage D, Salomon L, Alessi MC, Msika S, de Prost D. Microparticle increase in severe obesity: Not related to metabolic syndrome and unchanged after massive weight loss. Obesity (Silver Spring). 2013 Mar 20. doi: 10.1002/oby.20365.

Thouzeau S, Capdenat S, Stepanian A, Coppo P, Veyradier A. Evaluation of a commercial assay for ADAMTS13 activity measurement.
Thromb Haemost. 2013, 110, 852-853.

Unité 770 et EA4531

Badirou I, Kurdi M, Legendre P, Rayes J, Bryckaert M, Casari C, Lenting PJ, Christophe OD, Denis CV. In vivo analysis of the role of O-glycosylations of von Willebrand factor.
PLoS One. 2012, 7, e37508.

Beloncle F, Buffet M, Coindre JP, Munoz-Bongrand N, Malot S, Pène F, Mira JP, Galicier L, Guidet B, Baudel JL, Subra JF, Tanguy-Schmidt A, Pourrat J, Azoulay E, Veyradier A, Coppo P; for the Thrombotic Microangiopathies Reference Center. Splenectomy and/or cyclophosphamide as salvage therapies in thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.
Transfusion. 2012, 52, 2436-2444.

Benhamou Y, Assie’ C, Boelle PY, Buffet M, Grillberger R, Malot S, Wynckel A, Presne C, Choukroun G, Poullin P, Provôt F, Gruson D, Hamidou M, Bordessoule D, Pourrat J, Mira JP, Le Guern V, Pouteil-Noble C, Daubin C, Vanhille P, Rondeau E, Palcoux JB, Mousson C, Vigneau C, Bonmarchand G, Guidet B, Galicier L, Azoulay E, Rottensteiner H, Veyradier A, Coppo P. Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.
Haematologica. 2012, 97, 1181-1186.

Blomback M, Eikenboom J, Lane D, Denis C, Lillicrap D. von Willebrand disease biology.Haemophilia, 2012, 18 Suppl 4, 141-147.

Clauser S, Meilhac O, Bieche I, Raynald P, Brunevald P, Michel JB, Borgel D. Increased secretion of Gas6 by smooth muscle cells in human atherosclerotic carotid plaques. Thromb Haemost. 2012;107:140-149.

Delignat S, Repessé Y, Navarrete AM, Meslier Y, Gupta N, Christophe OD, Kaveri SV, Lacroix-Desmazes S. Immunoprotective effect of von Willebrand factor towards therapeutic factor VIII in experimental haemophilia A.
Haemophilia. 2012, 18, 248-254.

Denis CV, Lenting PJ. Von Willebrand factor : At the crossroads of bleeding and thrombosis.Int. J. Hematol. 2012, 95, 353-361.

Dimitrov JD, Christophe O, Kang J, Repessé Y, Delignat S, Kaveri SV, Lacroix-Desmazes S. Thermodynamic analysis of the interaction of factor VIII with von Willebrand factor. Biochemistry. 2012, 51, 4108-4116.

Froissart A, Buffet M, Veyradier A, Poullin P, Provôt F, Malot S, Schwarzinger M, Galicier L, Vanhille P, Vernant JP, Bordessoule D, Guidet B, Azoulay E, Mariotte E, Rondeau E, Mira JP, Wynckel A, Clabault K, Choukroun G, Presne C, Pourrat J, Hamidou M, Coppo P. Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center.
Crit Care Med. 2012, 40, 104-111.

Herrera Siklódy C, Arentz T, Minners J, Jesel L, Stratz C, Valina CM, Weber R, Kalusche D, Toti F, Morel O, Trenk D. Cellular damage, platelet activation, and inflammatory response after pulmonary vein isolation: a randomized study comparing radiofrequency ablation with cryoablation.
Heart Rhythm. 2012, 9, 189-196.

Kurdi M, Cherel G, Lenting PJ, Denis CV, Christophe OD. Coagulation factor X interaction with macrophages through its N-glycans protects it from a rapid clearance.
PLoS One. 2012, 7, e45111.

Labarthe B, Babin J, Bryckaert M, Théroux P, Bonnefoy A. Effects of P2Y(1) receptor antagonism on the reactivity of platelets from patients with stable coronary artery disease using aspirin and clopidogrel.
Br J Pharmacol. 2012, 166, 221-231.

Lenting PJ, Casari C, Christophe OD, Denis CV. Von Willebrand factor: the old, the new and the unknown.
J. Thromb. Haemost. 2012, 10, 2428-2437.

Lotta LA, Wu HM, Mackie IJ, Noris M, Veyradier A, Scully MA, Remuzzi G, Coppo P, Liesner R, Donadelli R, Loirat C, Gibbs RA, Horne A, Yang S, Garagiola I, Musallam KM, Peyvandi F. Residual plasmatic activity of ADAMTS13 correlates with phenotype severity in congenital thrombotic thrombocytopenic purpura.
Blood. 2012, 120, 440-448.

Moatti-Cohen M, Garrec C, Wolf M, Boisseau P, Galicier L, Azoulay E, Stepanian A, Delmas Y, Rondeau E, Bezieau S, Coppo P, Veyradier A. Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura.
Blood. 2012, 119, 5888-5897.

Moreau F, Toti F, Bayle F, Berney T, Egelhofer H, Chastre M, Richard MJ, Greget M, Masson D, Zobairi F, Benhamou PY, Kessler L; GRAGIL group. Rescue of a pancreatic islet graft after steroid therapy.
Transplantation, 2012, 93, e10-11.

Navarette AM, Casari C, Legendre P, Marx I, Hu JR, Lenting PJ, Christophe OD, Denis CV. A murine model to characterize the anti thrombotic effect of molecules targeting human von Willebrand factor.
Blood. 2012, 120, 2723-2732.

Pegon JN, Kurdi M, Casari C, Odouard S, Denis CV, Christophe OD, Lenting PJ. Factor VIII and von Willebrand factor are ligands for the carbohydrate-receptor Siglec-5. Haematologica, 2012, 97, 1855-1863.

Peigne V, Perez P, Resche Rigon M, Mariotte E, Canet E, Mira JP, Coppo P, Veyradier A, Azoulay E. Causes and risk factors of death in patients with thrombotic microangiopathies. Intensive Care Med. 2012, 38, 1810-1817.

Rastegarlari G, Pegon JN, Casari C, Odouard S, Navarrete AM, Saint-Lu N, van Vlijmen BJ, Legendre P, Christophe OD, Denis CV, Lenting PJ. Macrophage LRP1 contributes to the clearance of von Willebrand factor.
Blood. 2012, 119, 2126-2134.

Smadja D, Borgel D, Diehl JL, Gaussem P. VEGF, by contrast to PlGF, is increased in severe sepsis but not in organ failure.
J Thromb Haemost. 2012;10:974-976.

Saint-Lu N, Oortwijn BD, Pegon JN, Odouard S, Christophe OD, de Groot PG, Denis CV, Lenting PJ. Identification of Galectin-1 and Galectin-3 as Novel Partners for Von Willebrand Factor.
Arterioscler Thromb Vasc Biol. 2012, 32, 894-901.

Saposnik B, Peynaud-Debayle E, Stepanian A, Baron G, Simansour M, Mandelbrot L, de Prost D, Gandrille S. Elevated soluble endothelial cell protein C receptor (sEPCR) levels in women with preeclampsia: A marker of endothelial activation/damage?
Thromb Res. 2012, 129, 152-157.

Teyssandier M, Delignat S, Rayes J, Bryckaert M, Jandrot-Perrus M, Kaveri SV, Lacroix-Desmazes S. Activation state of platelets in experimental severe hemophilia A. Haematologica. 2012, 97, 1115-1116.

Veyradier A, Stepanian A, Coppo P. ADAMTS13, Thrombotic Thrombocytopenic Purpura and Pregnancy.
Hereditary Genetics 2012, S:1.http://dx.doi.org/10.4172/2161-1041.S1-002

Wolff M, Dorent R, Veyradier A, Deschamps L, Raffoul R. Heart transplantation for acute cardiac failure caused by thrombotic thrombocytopenic purpura (TTP).
Intensive Care Med. 2012, 38, 1908-1910.

Unité 770 et EA4531

Angelillo-Scherrer A, Fontana P, Burnier L, Roth I, Sugamele R, Brisset A, Morel S, Nolli S, Sutter E, Chassot A, Capron C, Borgel D, Saller F, Chanson M, Kwak BR. Connexin 37 limits thrombus propensity by downregulating platelet reactivity.
Circulation. 2011;124:930-939.

Bakouboula B, Morel O, Faller AL, Freyssinet JM, Toti F. Significance of membrane microparticles in solid graft and cellular transplantation.
Front Biosci. 2011, 17, 2499-2514.

Bianchini E, Fazavana J, Picard V and Borgel D. Development of a recombinant antithrombin variant as a potent antidote to fondaparinux and other heparin derivatives. Blood. 2011;117:2054-2060.

Bobe R, Hadri L, Lopez JJ, Sassi Y, Atassi F, Karakikes I, Liang L, Limon I, Lompré AM, Hatem SN, Hajjar RJ, Lipskaia L. SERCA2a controls the mode of agonist-induced intracellular Ca2+signal, transcription factor NFAT and proliferation in human vascular smooth muscle cells.J Mol Cell Cardiol. 2011, 50, 621-633.

Boisseau P, Giraud M, Ternisien C, Veyradier A, Fressinaud E, Lefrancois A, Bezieau S, Fouassier M. An unexpected transmission of von Willebrand disease type 3: the first case of maternal uniparental disomy 12.
Haematologica. 2011, 96, 1567-1568.

Chen J, Hobbs WE, Le J, Lenting PJ, de Groot PG, López JA. The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasma.Blood. 2011, 117, 3680-3683.

Denis CV, Dubois C, Brass LF, Heemskerk JW, Lenting PJ; Biorheology Subcommittee of the SSC of the ISTH. Towards standardization of in vivo thrombosis studies in mice.
J Thromb Haemost. 2011, 9, 1641-1644.

Desconclois C, Ract C, Boutekedjiret T, Alhenc-Gelas M, Duranteau J, Dreyfus M, Proulle V. Heparin-induced thrombocytopenia: successful biological and clinical management with lepirudin despite severe renal impairment.
Thromb Haemost. 2011, 105, 568-569.

Dionosio N, Albarrán L, López JJ, Berna-Erro A, Salido GM, Bobe R, Rosado JA. Acidic NAADP-releasable Ca(2+) compartments in the megakaryoblastic cell line MEG01.
Biochim Biophys Acta. 2011, 1813, 1483-1494.

Ducloy-Bouthors AS, Jude B, Duhamel A, Broisin F, Huissoud C, Keita-Meyer H, Mandelbrot L, Tillouche N, Fontaine S, Le Goueff F, Depret-Mosser S, Vallet B; EXADELI Study Group, Susen S. High-dose tranexamic acid reduces blood loss in postpartum haemorrhage.
Crit Care. 2011, 15, R117.

Hollestelle MJ, Loots CM, Squizzato A, Renné T, Bouma BJ, de Groot PG, Lenting PJ, Meijers JC, Gerdes VE. Decreased active von Willebrand factor due to shear stress in aortic stenosis patients.
J Thromb Haemost. 2011, 9, 953-958.

Lenting PJ. SHEARiO, fast lane to oxidized VWF.
Blood. 2011, 118, 5068-5069.

Morel O, Morel N, Jesel L, Freyssinet JM, Toti F. Microparticles: a critical component in the nexus between, inflammation, immunity and thrombosis.
Seminars in Immunopathology, 2011, 33, 469-486.

Morel O, Jesel L, Freyssinet JM, Toti F. Cellular mechanisms underlying the formation of circulating microparticles.
Arterioscler Thromb Vasc Biol. 2011, 31, 15-26.

Morel O, Luca F, Grunebaum L, Jesel L, Meyer N, Desprez D, Robert S, Dignat-George F, Toti F, Simon C, Goichot B. Short-term very low-calorie diet in obese females improves the haemostatic balance through the reduction of leptin levels, PAI-1 concentrations and a diminished release of platelet and leukocyte-derived microparticles.
Int J Obes (Lond). 2011, 35, 1479-1486.

Mosnier I, Stepanian A, Baron G, Bodenez C, Robier A, Meyer B, Fraysse B, Bertholon P, Defay F, Ameziane N, Ferrary E, Sterkers O, de Prost D. Cardiovascular and thromboembolic risk factors in idiopathic sudden sensorineural hearing loss: a case-control study.
Audiol Neuro-otol. 2011, 16, 55-66.

Nurden P, Debili N, Coupry I, Bryckaert M, Youlyouz-Marfak I, Solé G, Pons A-C, Berrou E, Adam F, Kauskot A, Lamazière J-M D, Rameau P, Fergelot P, Rooryck C, Cailley D, Arveiler B, Lacombe D, Vainchenker W, Nurden A, Goizet C. Thrombocytopenia resulting from mutations in filamin A can be expressed as an isolated syndrome.
Blood. 2011, 118, 5928-5937.

Oudghiri M, Keita H, Kouamou E, Boutonnet M, Orsini M, Desconclois C, Mandelbrot L, Daures JP, Stépanian A, Peynaud-Debayle E, de Prost D. Reference values for rotation thromboelastometry (ROTEM®) parameters following non-haemorrhagic deliveries. Correlations with standard haemostasis parameters.
Thromb Haemost. 2011, 106, 176-178.

Poindron V, Berat R, Knapp AM, Toti F, Zobairi F, Korganow AS, Chenard MP, Gounou C, Pasquali JL, Brisson A, Martin T. Evidence for Heterogeneity of the Obstetrical Antiphospholipid Syndrome: thrombosis can be Critical for Antiphospholipid-Induced Pregnancy Loss.
J Thromb Haemost. 2011, 9, 1937-1947.

Pouplard C, Caron C, Aillaud MF, Ternisien C, Desconclois C, Dubanchet A, Sobas F. The use of the new ReFacto AF Laboratory Standard allows reliable measurement of FVIII:C levels in ReFacto AF mock plasma samples by a one-stage clotting assay.
Haemophilia. 2011, 17:e958-962.

Schaff M, Receveur N, Bourdon C, Wurtz V, Denis CV, Orend G, Gachet C, Lanza F, Mangin PH. Novel Function of Tenascin-C, a Matrix Protein Relevant to Atherosclerosis, in Platelet Recruitment and Activation Under Flow.
Arterioscler Thromb Vasc Biol. 2011, 31, 117-124.

Stepanian A, Cohen-Moatti M, Sanglier T, Legendre P, Ameziane N, Tsatsaris V, Mandelbrot L, de Prost D, Veyradier A; for the ECLAXIR study group. Von Willebrand Factor and ADAMTS13: A Candidate Couple for Preeclampsia Pathophysiology.
Arterioscler Thromb Vasc Biol. 2011, 31, 1703-1709.

Toti F, Bayle F, Berney T, Egelhofer H, Richard MJ, Greget M, Masson D, Zobairi F, Benhamou PY, Kessler L. Studies of Circulating Microparticle Release in Peripheral Blood After Pancreatic Islet.
Transplant Proc. 2011, 43, 3241-3245.

Tosetto A, Rodeghiero F, Castaman G, Goodeve A, Federici AB, Batlle J, Meyer D, Goudemand J, Eikenboom J, Schneppenheim R, Budde U, Ingerslev J, Lethagen S, Hill FG, Peake I. A comparison between two semi-quantitative bleeding scales for the diagnosis and assessment of bleeding severity in type 1 von Willebrand disease.
Haemophilia. 2011, 17, 165-166.

Valarche V, Desconclois C, Boutekedjiret T, Dreyfus M, Proulle V. Multiplate whole blood impedance aggregometry: a new tool for von Willebrand disease.
J Thromb Haemost. 2011, 9, 1645-1647.

Veyradier A, Caron C, Ternisien C, Wolf M, Trossaert M, Fressinaud E, Goudemand J. Validation of the first commercial ELISA for type 2N von Willebrand’s disease diagnosis. Haemophilia. 2011, 17, 944-951.

Veyradier A, Fressinaud E, Goudemand J. Compound heterozygosity or heterozygosity with two mutations in cis on the same allele?: A rebuttal to the letter to the Editors: Koessler et al. Von Willebrand disease caused by compound heterozygosity for p.R854Q and p.R760C: diagnostic and therapeutic implications.
Haemophilia 2011; 17: e240-242.

Wootla B, Christophe OD, Mahendra A, Dimitrov JD, Repessé Y, Ollivier V, Friboulet A, Borel-Derlon A, Levesque H, Borg JY, Andre S, Bayry J, Calvez T, Kaveri SV, Lacroix-Desmazes S. Proteolytic antibodies activate factor IX in patients with acquired hemophilia.
Blood. 2011, 117, 2257-2264.

Unité 770 et EA4531

Adam F, Kauskot A, Nurden P, Sulpice E, Hoylaerts MF, Davis RG, Rosa JP, Bryckaert M. Platelet JNK1 is involved in secretion and thrombus formation.
Blood. 2010, 115, 4083-92.

Bal L, Ederhy S, Di Angelantonio E, Toti F, Zobairi F, Dufaitre G, Meuleman C, Mallat Z, Boccara F, Tedgui A, Freyssinet JM, Cohen A. Factors influencing the level of circulating procoagulant microparticles in acute pulmonary embolism.
Arch Cardiovasc Dis. 2010, 103, 394-403.

Badirou I, Kurdi M, Rayes J, Legendre P, Christophe OD, Lenting PJ, Denis CV. Von Willebrand factor clearance does not involve proteolysis by ADAMTS13.
J Thromb Haemost. 2010, 8, 2338-2340.

Boulaftali Y, Adam F, Venisse L, Ollivier V, Richard B, Taieb S, Monard D, Favier R, Alessi MC, Bryckaert M, Arocas V, Jandrot-Perrus M, and Bouton MC. Anticoagulant and antithrombotic properties of platelet protease nexin-1.
Blood. 2010, 115, 97-106.

Burnier L, Saller F, Kadi L, Brisset AC, Sugamele R, Baudino L, Bono F, Herbert JM, Carmeliet P, Schapira M, Izui S, Angelillo-Scherrer A. Gas6 deficiency in recipient mice of allogeneic transplantation alleviates hepatic graft-versus-host disease.
Blood. 2010;115: 3390-3397.

Castellana D, Toti F, Freyssinet JM. Membrane microvesicles: macromessengers in cancer disease and progression.
Thromb Res. 2010, 125 Suppl 2:S84-88.

Coppo P, Busson M, Veyradier A, Wynckel A, Poullin P, Azoulay E, Galicier L, Loiseau P; for the French Reference Centre for Thrombotic Microangiopathies. HLA-DRB1*11: a strong risk factor for acquired severe ADAMTS13 deficiency-related idiopathic thrombotic thrombocytopenic purpura in Caucasians.
J Thromb Haemost. 2010, 8, 856-859.

Coppo P, Schwarzinger M, Buffet M, Wynckel A, Clabault K, Presne C, Poullin P, Malot S, Vanhille P, Azoulay E, Galicier L, Lemiale V, Mira JP, Ridel C, Rondeau E, Pourrat J, Girault S, Bordessoule D, Saheb S, Ramakers M, Hamidou M, Vernant JP, Guidet B, Wolf M, Veyradier A; French Reference Center for Thrombotic Microangiopathies. Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience.
PLoS One. 2010, 5, e10208.

Dally, E. Corvazier, R. Bredoux, R. Bobe, J. Enouf. Multiple and diverse coexpression, location, and regulation of additional SERCA2 and SERCA3 isoforms in nonfailing and failing human heart.
J Mol Cell Card. 2010, 48, 633-644.

De Meyer SF, Schwarz T, Deckmyn H, Denis CV, Nieswandt B, Stoll G, Vanhoorelbeke K, Kleinschnitz C. Binding of von Willebrand Factor to Collagen and Glycoprotein Ib{alpha}, But Not to Glycoprotein IIb/IIIa, Contributes to Ischemic Stroke in Mice.
Arterioscler Thromb Vasc Biol. 2010, 30, 1949-1951.

Del Toro R, Prahst C, Mathivet T, Siegfried G, Larrivee B, Breant C, Duarte A, Takakura N, Penninger J, Eichmann A. Identification and functional analysis of endothelial tip cell-enriched genes.
Blood. 2010, 116, 4025-4033.

Fabre M, Leroy-Willig A, Denis CV, Ba N, Schoëvaërt D, Guettier C, Geldwerth-Feniger D. In vivo MRI and ex vivo quantification of iron and Kupffer cells demonstrate residual phagocytic activity in mouse liver after a gadolinium chloride injection.
Biochimie. 2010, 92, 1343-1353.

Freyssinet JM, Toti F. Formation of procoagulant microparticles and properties.
Thromb Res. 2010, 125 Suppl 1:S46-48.

Guéguen P, Cherel G, Badirou I, Denis CV, Christophe OD. Two residues in the activation peptide domain contribute to the half-life of factor X in vivo.
J Thromb Haemost. 2010, 8, 1651-1653.

Hadri L, Bobe R, Kawase Y, Ladage D, Ishikawa K, Atassi F, Lompré A-M, Kranias E G, Lebeche D, Lipskaia L and Hajjar R J. SERCA2a gene transfer enhances eNOS expression and activity in endothelial cells.
Mol Therapy. 2010, 18, 1284-1292.

Hechler B, Nonne C, Eckly A, Magnenat S, Rinckel JY, Denis CV, Freund M, Cazenave JP, Lanza F, Gachet C. Arterial thrombosis: relevance of a model with two levels of severity assessed by histological, ultrastructural and functional characterization.
J Thromb Haemost. 2010, 8, 173-184.

Hollestelle MJ, Sprong T, Bovenschen N, de Mast Q, van der Ven AJ, Joosten LA, Neeleman C, Hyseni A, Lenting PJ, de Groot PG, van Deuren M. Von Willebrand factor activation, granzyme-B and thrombocytopenia in meningococcal disease.
J Thromb Haemost. 2010, 8, 1098-1106.

Khatib AM, Lahlil R, Scamuffa N, Akimenko MA, Ernest S, Lomri A, Lalou C, Seidah NG, Villoutreix BO, Calvo F, Siegfried G. Zebrafish ProVEGF-C expression, proteolytic processing and inhibitory effect of unprocessed ProVEGF-C during fin regeneration.
PLoS One. 2010, 5 (7), e11438.

Lacroix R, Robert S, Poncelet P, Kasthuri RS, Key NS, Dignat-George F; ISTH SSC Workshop. Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop.
J Thromb Haemost. 2010, 8, 2571-2574.

Lenting PJ, Pegon JN, Groot E, de Groot PG. Regulation of von Willebrand factor-platelet interactions.
Thromb Haemost. 2010, 104, 449-455.

Lenting PJ, Christophe OD, Guéguen P. The disappearing act of factor VIII.
Haemophilia. 2010, 16, 6-15.

Lenting PJ, Pegon JN, Christophe OD, Denis CV. Factor VIII and von Willebrand factor–too sweet for their own good.
Haemophilia. 2010, 16 Suppl 5, 194-199.

Lenting PJ, Westerlaken GH, Denis CV, Akkerman JW, Meyaard L. Efficient inhibition of collagen-induced platelet activation and adhesion by LAIR-2, a soluble Ig-like receptor family member.
PLoS One. 2010, 5, e12174.

Lenting PJ, Rastegarlari G. ADAMTS-13: double trouble for von Willebrand factor.
J Thromb Haemost. 2010, 8, 2775-2777.

Meziani F, Delabranche X, Asfar P, Toti F. Bench-to-bedside review: circulating microparticles–a new player in sepsis?
Crit Care 2010, 14, 236.

Ojeda-Uribe M, Federici L, Wolf M, Veyradier A, Coppo P. Successful long-term rituximab maintenance for a relapsing patient with idiopathic thrombotic thrombocytopenic purpura.
Transfusion. 2010, 50, 733-735.

Peyvandi F, Hollestelle MJ, Palla R, Merlini PA, Feys HB, Vanhoorelbeke K, Lenting PJ, Mannucci PM. Active platelet-binding conformation of plasma von willebrand factor in young women with acute myocardial infarction.
J Thromb Haemost. 2010, 8, 1653-1656.

Rayes J, Hollestelle MJ, Legendre P, Marx I, de Groot PG, Christophe OD, Lenting PJ, Denis CV. Mutation & ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B.
Blood. 2010, 115, 4870-4877.

Schneider P, Van Dreden P, Rousseau A, Kassim Y, Legrand E, Vannier JP, Vasse M. Increased levels of tissue factor activity and procoagulant phospholipids during treatment of children with acute lymphoblastic leukaemia.
Br J Haematol. 2010;148:582-92.

Steevels TA, Westerlaken GH, Tijssen MR, Coffer PJ, Lenting PJ, Akkerman JW, Meyaard L. Co-expression of the collagen receptors leukocyte-associated immunoglobulin-like receptor-1 and glycoprotein VI on a subset of megakaryoblasts.
Haematologica. 2010, 95:2005-2012.

Turecek PL, Schrenk G, Rottensteiner H, Varadi K, Bevers E, Lenting P, Ilk N, Sleytr UB, Ehrlich HJ, Schwarz HP. Structure and Function of a Recombinant von Willebrand Factor Drug Candidate.
Semin Thromb Hemost. 2010, 36, 510-521.

van Schie MC, de Maat MP, de Groot PG, Hyseni A, Dippel DW, Lenting PJ, Leebeek FW, Hollestelle MJ. Active von Willebrand factor and the risk of stroke.
Atherosclerosis, 2010, 208, 322-323.

van Schie MC, de Maat MP, Dippel DW, de Groot PG, Lenting PJ, Leebeek FW, Hollestelle MJ. Von Willebrand factor propeptide and the occurrence of a first ischemic stroke.
J Thromb Haemost. 2010, 8, 1424-1426.

Jean Solarz : prix jeune chercheur CFMP, Bordeaux 2022

Thibaud Séfiane : prix du CFH, Bordeaux 2022